voriconazole has been researched along with posaconazole in 413 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (1.69) | 18.2507 |
| 2000's | 115 (27.85) | 29.6817 |
| 2010's | 257 (62.23) | 24.3611 |
| 2020's | 34 (8.23) | 2.80 |
| Authors | Studies |
|---|---|
| Dierich, MP; Lass-Flörl, C; Lugger, H; Perkhofer, S | 1 |
| Bouza, E; Guinea, J; Martínez-Alarcón, J; Peláez, T; Torres-Narbona, M | 1 |
| Alcázar-Fuoli, L; Cuenca-Estrella, M; Garcia-Effron, G; Melchers, WJ; Mellado, E; Rodríguez-Tudela, JL; Verweij, PE | 1 |
| Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA | 1 |
| Dannaoui, E; Datry, A; Dromer, F; Hoinard, D; Lacroix, C; Lortholary, O; Paugam, A; Poirot, JL; Raoux, D | 1 |
| Chatzimoschou, A; Dalakiouridou, M; Diza-Mataftsi, E; Katragkou, A; Roilides, E; Simitsopoulou, M; Tsantali, C | 1 |
| Cano, J; Gené, J; Guarro, J; Marimon, R; Serena, C | 1 |
| Alastruey-Izquierdo, A; Alcazar-Fuoli, L; Cuenca-Estrella, M; Mellado, E; Rodriguez-Tudela, JL | 2 |
| Boekhout, T; Curfs-Breuker, I; Fernández, CM; Illnait-Zaragozi, MT; Martínez, GF; Meis, JF | 1 |
| Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL | 1 |
| Azor, M; Cano, J; Fothergill, AW; Gené, J; Guarro, J; Rinaldi, MG; Sutton, DA | 1 |
| Dho, G; Esposto, MC; Gianni, C; Grancini, A; Ossi, C; Prigitano, A; Tortorano, AM; Viviani, MA | 1 |
| Chu, CC; Hsueh, PR; Ruan, SY | 1 |
| Alastruey-Izquierdo, A; Alcazar-Fuoli, L; Cuenca-Estrella, M; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
| Alastruey-Izquierdo, A; Castelli, MV; Cuenca-Estrella, M; Cuesta, I; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
| Fille, M; Hausdorfer, J; Hinterberger, G; Lass-Flörl, C; Mayr, A; Perkhofer, S; Speth, C | 1 |
| Müller, FM; Salvenmoser, S; Seidler, MJ | 1 |
| Garcia-Effron, G; Kontoyiannis, DP; Lewis, RE; Perlin, DS | 1 |
| Fothergill, AW; Patterson, TF; Thompson, GR; Vallor, AC; Wickes, BL; Wiederhold, NP | 1 |
| Alastruey-Izquierdo, A; Cuenca-Estrella, M; Lass-Flörl, C; Perkhofer, S; Rodriguez-Tudela, JL | 1 |
| Arendrup, MC; Bruun, B; Buzina, W; Garcia-Effron, G; Jensen, HE; Lass-Flörl, C; Lundin, C; Mortensen, KL; Perlin, DS; Reiter, N | 1 |
| Dimopoulos, G; Falagas, ME; Velegraki, A | 1 |
| Lass-Flörl, C; Lechner, V; Perkhofer, S | 1 |
| Alastruey-Izquierdo, A; Castelli, MV; Cuenca-Estrella, M; Cuesta, I; Monzon, A; Rodriguez-Tudela, JL | 1 |
| Guarro, J; Mariné, M; Rodríguez, MM; Ruíz-Cendoya, M | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 2 |
| Heinz, WJ; Helle, A; Kahle, K; Keller, D; Klinker, H; Langmann, P; Lenker, U; Schirmer, D | 1 |
| Guarro, J; Mariné, M; Pastor, FJ; Serena, C | 1 |
| Chittick, P; Delashmitt, B; Evans, J; Palavecino, EL; Peacock, JE | 1 |
| Calvo, E; Guarro, J; Pastor, FJ; Rodríguez, MM; Salas, V; Sutton, DA | 1 |
| Gao, C; Pang, G; Sun, S; Wang, B; Xu, Y; Zhao, D; Zhou, L | 1 |
| Brüggemann, RJ; Mavridou, E; Melchers, WJ; Mouton, JW; Verweij, PE | 1 |
| Badali, H; De Hoog, GS; Illnait-Zaragozi, MT; Meis, JF; Najafzadeh, MJ | 1 |
| Coste, A; Ischer, F; Jacobsen, MD; MacCallum, DM; Odds, FC; Sanglard, D | 1 |
| Karawajczyk, A; Melchers, WJ; Schaftenaar, G; Snelders, E; Verweij, PE | 1 |
| Alastruey-Izquierdo, A; Cuenca-Estrella, M; Cuesta, I; Rodriguez-Tudela, JL; Walther, G | 1 |
| Bauer, T; Cornely, OA; Farowski, F; Hartmann, P; Müller, C; Rüping, MJ; Steinbach, A; Vehreschild, JJ | 1 |
| Bartley, R; Biswas, C; Chen, SC; Djordjevic, JT; Ellis, DH; Jolliffe, KA; Obando, D; Pantarat, N; Sorrell, TC; Widmer, F | 1 |
| Baietto, L; D'Avolio, A; De Rosa, FG; Di Perri, G; Sciandra, M; Siccardi, M; Simiele, M; Ventimiglia, G | 1 |
| Calvo, E; Guarro, J; Mayayo, E; Pastor, FJ; Rodríguez, MM; Salas, V | 1 |
| Bouza, E; Escribano, P; Gama, B; Guinea, J; Peláez, T; Recio, S | 1 |
| Kelly, DE; Kelly, SL; Martel, CM; Melo, N; Nes, WD; Parker, JE; Warrilow, AG | 1 |
| Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Rolley, NJ; Warrilow, AG | 1 |
| Guarro, J; Mayayo, E; Pastor, FJ; Pujol, I; Ruíz-Cendoya, M; Sutton, DA | 1 |
| Arendrup, MC; Johansen, HK; Lass-Flörl, C; Mellado, E; Mortensen, KL; Rodriguez-Tudela, JL | 1 |
| Aiello, S; Borghi, E; Boschi, D; Fruttero, R; Guglielmo, S; Morace, G | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Garvey, EP; Hoekstra, WJ; Moore, WR; Rafferty, SW; Schotzinger, RJ; Yates, CM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chandrika, NT; Garneau-Tsodikova, S; Ngo, HX; Shrestha, SK | 1 |
| Garneau-Tsodikova, S; Garzan, A; Shrestha, SK | 1 |
| Emami, S; Keighobadi, M; Tavangar, P | 1 |
| Blobaum, AL; Botta, M; Friggeri, L; Guengerich, FP; Hargrove, TY; Lepesheva, GI; Lindsley, CW; Nes, WD; Rachakonda, G; Villalta, F; Wawrzak, Z | 1 |
| Wang, SQ; Wang, YF; Xu, Z | 1 |
| Benhamou, RI; Dorot, O; Elias, R; Fridman, M; Jaber, QZ; Oved, K; Pichinuk, E; Zada, SL | 1 |
| Gazzola, S; Guillon, R; Le Pape, P; Logé, C; Montoir, D; Ourliac-Garnier, I; Pagniez, F; Picot, C; Planchat, A; Soklou, KE; Tonnerre, A | 1 |
| Hashimoto, K; Kato, I; Kawai, M; Kimura, C; Kondo, N; Maki, H; Mizusawa, E; Naito, A; Nozu, K; Ukai, Y | 1 |
| Guengerich, FP; Hargrove, TY; Lepesheva, GI; Nes, WD; Rachakonda, G; Villalta, F; Wawrzak, Z | 1 |
| Hitchcock, CA; Koltin, Y | 1 |
| Cantu, RA; Fothergill, AW; Kirkpatrick, WR; Lopez-Ribot, JL; Mcatee, RK; McCarthy, DI; Patterson, TF; Revankar, SG; Rinaldi, MG; Sanche, SE | 1 |
| Baquero, F | 1 |
| Brandt, ME; Doern, GV; Hajjeh, RA; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Chandrasekar, PH; Cutright, J; Manavathu, EK | 1 |
| Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ | 1 |
| Matsushima, T; Nakajima, M; Niki, Y | 1 |
| Fothergill, AW; Rinaldi, MG; Saracli, MA; Yildiran, ST | 1 |
| Chandrasekar, PH; Cutright, JL; Loebenberg, D; Manavathu, EK | 1 |
| Abraham, OC; Chandrasekar, PH; Manavathu, EK | 1 |
| Carrillo, AJ; Guarro, J | 1 |
| Chandrasekar, PH; Cutright, JL; Manavathu, EK | 1 |
| Denning, DW; Mosquera, J | 1 |
| Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Huynh, H; Messer, SA; Pfaller, MA | 1 |
| Espinel-Ingroff, A; Rezusta, A | 1 |
| Gil-Lamaignere, C; Maloukou, A; Mosquera, J; Roilides, E; Walsh, TJ | 1 |
| Habel, F; Hoban, D; Laverdiere, M; Restieri, C | 1 |
| Bastide, JM; Dannaoui, E; Grillot, R; Mallie, M; Meletiadis, J; Piens, MA; Rigoni, AL; Tortorano, AM; Viviani, MA | 1 |
| Chen, E; Ostrosky-Zeichner, L; Paetznick, VL; Paphitou, NI; Rex, JH; Rodriguez, JR | 1 |
| Fothergill, AW; Rinaldi, MG; Sutton, DA; Yildiran, ST | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Kamei, K | 1 |
| Sutton, DA | 1 |
| Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Gupta, AK; Tomas, E | 1 |
| Benito, R; Gil, J; Ramírez de Ocáriz, I; Rezusta, A; Rubio Calvo, MC | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA; Rice, C; Tendolkar, S | 1 |
| Bocanegera, R; Colombo, AL; Gonzalez, GM; Graybill, JR; Hernandez, S; McCarthy, DI; Najvar, LK | 1 |
| Gavaldá, J; Lumbreras, C | 1 |
| Espinel-Ingroff, A; Jones, RN; Pfaller, MA | 1 |
| Gil-Lamaignere, C; Hess, R; Heyn, K; Kappe, R; Müller, FM; Salvenmoser, S | 1 |
| Steinbach, WJ | 1 |
| Fothergill, AW; González, GM; Loebenberg, D; Rinaldi, MG; Sutton, DA | 1 |
| Barchiesi, F; Cuenca-Estrella, M; Espinel-Ingroff, A; Pfaller, MA; Rinaldi, M; Rodriguez-Tudela, JL; Verweij, PE | 1 |
| Jagirdar, J; Scott, RS; Sutton, DA | 1 |
| Barchiesi, F; Cuenca-Estrella, M; Espinel-Ingroff, A; Fothergill, A; Pfaller, MA; Rinaldi, M; Rodriguez-Tudela, JL; Verweij, PE | 1 |
| Espinel-Ingroff, A; Fothergill, A; Ghannoum, M; Manavathu, E; Ostrosky-Zeichner, L; Pfaller, M; Rinaldi, M; Schell, W; Walsh, T | 1 |
| Baker, CJ; Pannaraj, PS; Walsh, TJ | 1 |
| Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G | 1 |
| Barfield, RC; Behm, FG; Burnette, K; Eldridge, P; Hale, GA; Handgretinger, R; Knapp, K | 1 |
| Black, TA; Hare, R; Loebenberg, D; Mann, PA; McNicholas, PM; Mendrick, CA; Norris, CC; Patel, R; Sabatelli, F | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL | 1 |
| Aperis, G; Mylonakis, E | 1 |
| Colson, YL; Marty, FM; Paul, S | 1 |
| Chryssanthou, E; Cuenca-Estrella, M | 1 |
| Aperis, G; Mylonakis, E; Spanakis, EK | 1 |
| Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
| Denning, DW; Gardiner, RE; Howard, SJ; Moore, CB; Park, S; Perlin, DS; Webster, I | 1 |
| Arthington-Skaggs, B; Ellis, D; Espinel-Ingroff, A; Fothergill, A; Gibbs, DL; Iqbal, N; Messer, S; Pfaller, MA; Rinaldi, M; Wang, A | 1 |
| Harada, AS; Lau, W | 1 |
| Amedro, P; Blayac, JP; Cociglio, M; Eiden, C; Hillaire-Buys, D; Margueritte, G; Peyrière, H; Tichit, R | 1 |
| Alcalá, L; Bouza, E; Guinea, J; Peláez, T | 1 |
| Kontoyiannis, DP; Lewis, RE | 1 |
| Acharya, NR; Chidambaram, JD; Fothergill, AW; Hong, KC; Lalitha, P; Lietman, TM; Maxey, KJ; McLeod, SD; Prajna, NV; Ruiz, J; Shapiro, BL; Srinivasan, M | 1 |
| Geiger, S; Herold, T; Nickenig, C; Ostermann, H; Rieger, C | 1 |
| Foo, H; Gottlieb, T | 1 |
| Park, AJ; Tu, EY | 1 |
| Kauffman, CA; Malani, AN | 1 |
| Chen, SC; Sorrell, TC | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA; Tendolkar, S | 1 |
| Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA | 1 |
| Arthington-Skaggs, BA; Chaturvedi, V; Ghannoum, MA; Holliday, N; Iqbal, NJ; Killian, SB; Knapp, C; Messer, SA; Ostrosky-Zeichner, L; Pfaller, MA; Ramani, R; Rex, JH; Sein, T; Vazquez, JA; Walsh, TJ | 1 |
| Gil-Lamaignere, C; Maloukou, A; Roilides, E; Simitsopoulou, M; Walsh, TJ | 1 |
| Andes, D; Smith, J | 1 |
| Alvarado-Ramírez, E; Murciano, F; Sellart, M; Torres-Rodríguez, JM | 1 |
| Lortholary, O | 1 |
| Lipp, HP | 1 |
| Antoniadis, A; Braimi, M; Dermitzakis, E; Kioumi, A; Papadakis, E; Tsitouridis, I; Vyzantiadis, TA | 1 |
| Ananda-Rajah, MR; Grigg, A; Slavin, MA | 1 |
| Ben-Ami, R; Kontoyiannis, DP; Lamaris, GA; Lewis, RE | 1 |
| Ayala, J; Elizondo, M; González, GM | 1 |
| Altas, K; Boekhout, T; Kantarcioğlu, AS; Yücel, A | 1 |
| Bosch, M; Cantón, E; Espinel-Ingroff, A; Gobernado, M; Pemán, J; Valentín, A | 1 |
| Hollenbach, E | 1 |
| Brown, TA; Grooters, AM; Hosgood, GL | 1 |
| Donders, AR; Kuijpers, J; Melchers, WJ; Mellado, E; Rijs, AJ; Samson, RA; Snelders, E; van der Lee, HA; Varga, J; Verweij, PE | 1 |
| Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Touw, DJ; Verweij, PE | 1 |
| Bearman, G; Pakyz, A | 1 |
| Kisac, P; Krcmery, V; Liskova, A | 1 |
| Fothergill, AW; Rinaldi, MG; Sutton, DA | 1 |
| Alp, S; Arikan, S; Hascelik, G; McNicholas, P; Sancak, B | 1 |
| Amrein, C; Benammar, M; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Lefeuvre, S | 1 |
| Maschmeyer, G | 1 |
| Costa-de-Oliveira, S; Pina-Vaz, C; Pinto e Silva, AT; Rodrigues, AG; Silva-Dias, A | 1 |
| Baggen, L; Chisholm, J; Sharland, M; Thomas, L | 1 |
| de La Blanchardière, A; de La Gastine, B; Fromager, G; Gendrot, A; Massias, L; Verdon, R | 1 |
| Abboud, I; Antoine, C; Benammar, M; Berge, M; Billaud, EM; Glotz, D; Lefeuvre, S | 1 |
| Accoceberry, I; Bernadou, JM; Breilh, D; Gordien, JB; Pigneux, A; Rouault, A; Saux, MC; Tabrizi, R; Vigouroux, S | 1 |
| Balajee, SA; Brandt, ME; Gade, L; McCloskey, CB | 1 |
| Denning, DW; Howard, SJ; Pasqualotto, AC | 1 |
| Alastruey-Izquierdo, A; Castelli, MV; Cuesta, I; Mellado, E; Monzón, A; Rodríguez-Tudela, JL; Zaragoza, O | 1 |
| Guarro, J; Madrid, H; Pastor, J; Ruíz-Cendoya, M | 1 |
| Cornely, OA | 1 |
| Georgiadou, E; Roilides, E; Simitsopoulou, M; Walsh, TJ | 1 |
| Al-Badriyeh, D; Bajel, A; Downey, M; Grigg, A; Kong, DC; Liew, D; Slavin, M; Stewart, K; Thursky, K | 1 |
| Vera-Cabrera, L; Welsh, E; Welsh, O | 1 |
| Dirr, F; Ebel, F; Echtenacher, B; Heesemann, J; Hoffmann, P; Wagener, J | 1 |
| Arnold, TM; Dotson, E; Hage, CA; Sarosi, GA | 1 |
| Kondori, N; Mattsby-Baltzer, I; Svensson, E | 1 |
| Canton, E; Diekema, DJ; Espinel-Ingroff, A; Fothergill, A; Johnson, E; Pelaez, T; Pfaller, MA; Rinaldi, MG; Turnidge, J | 1 |
| McCormack, J; Pollard, J | 1 |
| Calvo, E; Guarro, J; Pastor, FJ; Pujol, I; Rodríguez, MM | 1 |
| Heeres, J; Lewi, P; Meerpoel, L | 1 |
| Cordonnier, C; Cornely, OA; Flückiger, U; Frêre, P; Gachot, B; Heinz, WJ; Herbrecht, R; Lass-Flörl, C; Maertens, J; Marchetti, O; Ribaud, P; Thiebaut, A | 1 |
| Bowyer, P; Bueid, A; Denning, DW; Harrison, E; Howard, SJ; Moore, CB; Richardson, MD | 1 |
| Cutlan, JE; Geddes, ER; Hymes, SR; Polder, K; Torres-Cabala, CA | 1 |
| Guarro, J; Pastor, J; Ruíz-Cendoya, M | 1 |
| Bartlett, KH; Boekhout, T; Geertsen, E; Hagen, F; Illnait-Zaragozi, MT; Klaassen, CH; Meis, JF; Swinne, D | 1 |
| Bille, J; Calandra, T; Decosterd, LA; Marchetti, O; Mercier, T; Pesse, B; Rochat, B; Tissot, F; Widmer, N; Zanolari, B | 1 |
| Chen, DM; Guo, LN; Liu, Y; Lü, HX; Shi, JY; Shi, Y; Wang, H; Xi, LY; Xu, YC; Zhao, WS; Zhou, X | 1 |
| Alanio, A; Botterel, F; Bretagne, S; Cordonnier, C; Costa, JM; Farrugia, C; Foulet, F; Hicheri, Y; Liance, M; Sitterlé, E | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S | 1 |
| Boyken, L; Diekema, D; Hollis, R; Kroeger, J; Messer, S; Pfaller, M; Tendolkar, S | 1 |
| Boyken, L; Diekema, DJ; Espinel-Ingroff, A; Hollis, RJ; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S | 1 |
| Cornely, OA; Farowski, F; Hussaini, T; Rüping, MJ; Vehreschild, JJ | 1 |
| Andes, D; Bastulli, C; Chaturvedi, V; Diekema, DJ; Ghannoum, MA; Iqbal, N; Knapp, C; Lockhart, SR; Marchillo, K; Messer, S; Ostrosky-Zeichner, L; Paetznick, VL; Pfaller, MA; Ramani, R; Rodriguez, J; Sein, T; Walsh, TJ; Welshenbaugh, AR | 1 |
| Boyken, LB; Diekema, DJ; Hollis, RJ; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S | 1 |
| Bouza, E; Escribano, P; Guinea, J; Peláez, T; Recio, S | 1 |
| Antachopoulos, C; Chatzimoschou, A; Georgiadou, E; Katragkou, A; Roilides, E; Simitsopoulou, M; Walsh, TJ | 1 |
| Ananda-Rajah, MR; Cheng, A; Dooley, M; Morrissey, CO; Neville, AM; Slavin, M; Spelman, T | 1 |
| Maschmeyer, G; Sandherr, M | 1 |
| Karthaus, M | 1 |
| Amorim, A; Butler, G; Guida, A; Miranda, IM; Pina-Vaz, C; Rocha, R; Rodrigues, AG; Silva, AP; Silva, R; Synnott, J | 1 |
| Arendrup, MC; Fuursted, K; Gahrn-Hansen, B; Howard, SJ; Jensen, RH; Johansen, HK; Knudsen, JD; Mortensen, KL | 1 |
| Calvo, E; Guarro, J; Hernández, P; Mayayo, E; Pastor, FJ | 1 |
| Badali, H; de Hoog, GS; Meis, JF; Sudhadham, M | 1 |
| Baxter, CG; Denning, DW; Felton, TW; Marshall, A; Roberts, M | 1 |
| Castanheira, M; Hata, K; Jones, RN; Messer, SA; Moet, GJ; Pfaller, MA | 1 |
| Chavala, SH; Ehlers, JP; Postel, EA; Woodward, JA | 1 |
| Lingegowda, PB; Tan, AL; Tan, BH; Tan, CK | 1 |
| Björkholm, M; Celsing, F; Grane, P; Kalin, M | 1 |
| Carrillo-Muñoz, AJ; Eraso, E; Madariaga, L; Marcos-Arias, C; Quindós, G | 1 |
| Castanheira, M; Diekema, DJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Cafarchia, C; Figueredo, LA; Iatta, R; Montagna, MT; Otranto, D | 1 |
| Bays, D; Cohen, SH; Pappagianis, D; Thompson, GR | 1 |
| Bouza, E; Escribano, P; González-Rivera, M; Guinea, J; Peláez, T; Recio, S | 1 |
| Hirano, K; Hosogaya, N; Ide, S; Imamura, Y; Iwanaga, N; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Mihara, T; Minematsu, A; Miyazaki, T; Morinaga, Y; Nakamura, S; Nishino, T; Takazono, T; Tashiro, M; Tashiro, T; Tsukamoto, M; Yamamoto, Y; Yanagihara, K; Yasuoka, A | 1 |
| Blair, JE; Kim, MM; Kusne, S; Seville, MT; Vikram, HR | 1 |
| Ananda-Rajah, MR; Bajel, A; Cheng, A; Downey, MT; Grigg, A; Slavin, MA; Spelman, T; Thursky, KT; Vincent, J | 1 |
| Castanheira, M; Diekema, DJ; Duncanson, FP; Guarro, J; Jones, RN; Pfaller, MA | 1 |
| Lass-Flörl, C | 1 |
| Chang, YC; Dolan, MA; Garraffo, HM; Ghannoum, MA; Kwon-Chung, KJ; Sionov, E | 1 |
| de Hoog, GS; Mahgoub, el-S; van de Sande, WW; van Diepeningen, AD | 1 |
| Curfs-Breuker, I; de Hoog, GS; Klaassen, CH; Lackner, M; Meis, JF; Najafzadeh, MJ; Verweij, PE | 1 |
| Campos-Herrero, MI; Horcajada, I; Medina-Rivero, F; Tandón, L | 1 |
| Mavridou, E; Melchers, WJ; Meletiadis, J; Mouton, JW; Verweij, PE | 1 |
| Chishimba, L; Cooley, J; Denning, DW; Niven, RM | 1 |
| Egerer, G | 1 |
| Aubin, GG; Bretagne, S; Danner-Boucher, I; Garcia-Hermoso, D; Haloun, A; Le Pape, P; Miegeville, M; Morio, F; Sacchetto, E | 1 |
| Kema, GH; Melchers, WJ; van de Sande-Bruisma, N; Verweij, PE | 1 |
| Egli, A; Fuller, J; Humar, A; Kapasi, A; Kumar, D; Lien, D; Nador, R; Weinkauf, J | 1 |
| Beltran, C; Bourge, RC; Bourke, P; Castro, P; Rabagliati, R; Verdejo, H; Winter, JL | 1 |
| Calvo, E; Fothergill, AW; Guarro, J; Pastor, FJ; Rinaldi, MG; Salas, V; Sutton, DA | 1 |
| Fasler, D; Gerber, B; Guggenberger, R; Manz, MG; Nair, G; Schanz, U; Stussi, G | 1 |
| Chandrasekar, PH; Cutright, JL; Krishnan Natesan, S; Wu, W | 1 |
| Ahmed, S; de Hoog, GS; Feng, P; Klaassen, CH; Lai, W; Lu, C; Meis, JF; Najafzadeh, MJ; Sun, J; Xi, L | 1 |
| Aller, AI; Canton, E; Castañón-Olivares, LR; Chowdhary, A; Cordoba, S; Cuenca-Estrella, M; Espinel-Ingroff, A; Fothergill, A; Fuller, J; Govender, N; Hagen, F; Illnait-Zaragozi, MT; Johnson, E; Kidd, S; Lass-Flörl, C; Lockhart, SR; Martins, MA; Meis, JF; Melhem, MS; Ostrosky-Zeichner, L; Pelaez, T; Pfaller, MA; Schell, WA; St-Germain, G; Trilles, L; Turnidge, J | 1 |
| Abu El-Naaj, I; Leiser, Y; Peled, M; Wolff, A | 1 |
| Barclay, ML; Begg, EJ; Moore, GA; Zhang, M | 1 |
| Boehme, A; Egerer, G; Greiner, J; Heinz, WJ; Lellek, H | 1 |
| Ahmed, R; Akdal, G; Ananda, A; Chan, R; Chiu, AL; Crompton, JL; Francis, I; Ghabrial, R; Gibson, J; Goold, LA; Halmagyi, GM; Madge, SN; McCluskey, PJ; Rodriguez, M; Selva, D; Thompson, EO; Thurtell, MJ | 1 |
| Husain, S; Luong, ML; Rotstein, C | 1 |
| Albarrag, AM; Anderson, MJ; Bowyer, P; Denning, DW; Gregson, L; Harrison, E; Howard, SJ; Leatherbarrow, H; Pasqualotto, AC | 1 |
| Badali, H; Curfs-Breuker, I; de Hoog, GS; Deng, S; Liao, W; Meis, JF; Najafzadeh, MJ; Pan, B; Yang, L | 1 |
| Bouchara, JP; Diquet, B; Franconi, F; Godon, C; Legras, P; Lelièvre, B; Saint-André, JP | 1 |
| Al-Badriyeh, D; Bajel, A; Grigg, A; Heng, SC; Kirsa, S; Kong, DC; Nation, RL; Seymour, JF; Slavin, MA; Thursky, K | 1 |
| Chowdhary, A; Kathuria, S; Khan, N; Kumar, DA; Meis, JF; Muralidhar, S; Prakash, A; Randhawa, HS; Sharma, C; Singh, PK; Wankhede, S | 1 |
| Cano, J; Crous, PW; da Cunha, KC; Fothergill, AW; Gené, J; Guarro, J; Hoog, Sd; Madrid, H; Sutton, DA | 1 |
| Mast, N; Pikuleva, IA; Stout, CD; Zheng, W | 1 |
| Bader, O; Buchheidt, D; Christner, M; Groß, U; Held, J; Kuhns, M; Lugert, R; Peter, S; Reichard, U; Schumacher, U; Tintelnot, K; Weig, M | 1 |
| Benjamin, DK; Ericson, J; Manzoni, P | 1 |
| Biswas, C; Chen, SC; Djordjevic, JT; Jolliffe, KA; Sorrell, TC; Zuo, X | 1 |
| Arikan-Akdagli, S; Canton, E; Hazirolan, G; Sahin, S | 1 |
| Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Johnson, A; McEntee, L; Moore, CB; Richardson, M | 1 |
| Brüggemann, RJ; Mouton, JW; Seyedmousavi, S; Verweij, PE | 1 |
| Capilla, J; Fernández-Silva, F; Guarro, J; Hernández, P; Mayayo, E; Sutton, DA | 1 |
| Curfs-Breuker, I; de Hoog, GS; Feng, P; Meis, JF; Najafzadeh, MJ; Rezaei-Matehkolaei, A; Saradeghi Keisari, M; Shamsian, SA; Vicente, VA | 1 |
| Dupont, L; Lagrou, K; Maertens, J; Meersseman, P; Saegeman, V; Vermeulen, E | 1 |
| Adamski, Z; Gil, L; Komarnicki, M; Kubisiak-Michalska, A; Kubisiak-Rzepczyk, H; Mol, A; Reich, A; Zawirska, A | 1 |
| Dorsey, SA; Fothergill, AW; Furmaga, W; Lewis, JS; Patterson, TF; Pennick, GJ; Sutton, DA; Wiederhold, NP | 1 |
| Goletz, G; Groll, AH; Jürgens, H; Kolve, H; Pieper, S; Yunus, S | 1 |
| Capilla, J; Fernández-Silva, F; Guarro, J; Mayayo, E; Sutton, D | 1 |
| Gomes, MZ; Jiang, Y; Kontoyiannis, DP; Lewis, RE; Mulanovich, VE | 2 |
| Cuenca-Estrella, M; Escribano, P; Guinea, J; Martín-Mazuelos, E; Pemán, J; Sánchez-Reus, F; Zaragoza, Ó | 1 |
| Bonfietti, LX; Bustamante, B; Canton, E; Espinel-Ingroff, A; Fothergill, A; Fuller, J; Gonzalez, GM; Guarro, J; Lass-Flörl, C; Lockhart, SR; Martin-Mazuelos, E; Meis, JF; Melhem, MS; Ostrosky-Zeichner, L; Pelaez, T; Pfaller, MA; St-Germain, G; Szeszs, MW; Turnidge, J | 1 |
| Mitra, AK; Pal, D; Patel, M; Paturi, DK; Vadlapatla, RK | 1 |
| Aguiar, A; Faria, M; Fernandes, C; Lago, M; Natário, A; Pinto, E | 1 |
| Kauffman, CA; Kerr, L; Malani, AN; Obear, J; Singal, B | 1 |
| Fung, HC; Peksa, GD; Schultz, K | 1 |
| Cooke, RP; Denning, DW; Ellenbogen, JR; Javadpour, M; Lesser, T; Skinner, DW; Waqar, M | 1 |
| Capilla, J; Fothergill, AW; Guarro, J; Mayayo, E; Paredes, K; Sutton, DA | 1 |
| Azie, NE; Franks, B; Freifeld, AG; Horn, DL; Kauffman, CA; Schuster, MG | 1 |
| Chowdhary, A; Hagen, F; Meis, JF; Sharma, C | 1 |
| Alfonso, EC; Iovieno, A; Ledee, DR; Miller, D | 1 |
| Capilla, J; Fothergill, AW; Guarro, J; Pastor, FJ; Sanchis, M; Sutton, DA | 1 |
| Brüggemann, RJ; Melchers, WJ; Mouton, JW; Seyedmousavi, S; Verweij, PE | 1 |
| Aquino, VR; Bergamasco, MD; Castro, PT; Colombo, AL; Gonçalves, SS; Negri, CE; Xafranski, H | 1 |
| Akshita, K; Datry, A; Fekkar, A; Lescar, J; Mazier, D; Meyer, I; Palous, M; Srinivasaraghavan, K; Verma, C | 1 |
| Dolton, MJ; McLachlan, AJ | 1 |
| Amazzough, K; Arvieux, C; Barete, S; Bougnoux, ME; Crabol, Y; Lanternier, F; Lecuit, M; Lortholary, O; Maunoury, C; Pineau, S; Poiree, S; Zeller, V | 1 |
| Alfaya Muñoz, L; Avendaño Cantos, EM; Celis Sánchez, J; Mesa Varona, D; Romero Moraleda, L | 1 |
| Cassumbhoy, M; Chau, MM; Cooper, CM; Kong, DC; Marriott, DJ; Roberts, JA; Trubiano, JA; Urbancic, K; van Hal, SJ; Wilkes, J; Worth, LJ | 1 |
| Bosschaerts, T; Boulet, G; Cos, P; Fortin, A; Maes, L; Paulussen, C | 1 |
| Kohn, R; Kotton, CN; Markmann, JF; Patel, MS; Vagefi, PA; Wright, AJ | 1 |
| Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Conant, MM; Proia, LA; Sha, BE | 1 |
| Badali, H; de Hoog, GS; Mashedi, O; Meis, JF; Mohammadi, R | 1 |
| Marr, K; Ostrander, D; Shoham, S | 1 |
| Goeman, E; Kidd, SE; Meis, JF; Slavin, MA; Verweij, PE | 1 |
| Chang, SC; Ko, BS; Lee, SH; Sun, HY | 1 |
| Chang, YC; Eckhaus, MA; Fedorova, N; Figat, A; Joardar, V; Kwon-Chung, KJ; Losada, L; Mounaud, S; Nierman, WC; Pakala, S; Pakala, SB; Sugui, JA; Venepally, P | 1 |
| Ağca, H; Ak, S; Akalın, H; Cilo, BD; Ener, B; Özmerdiven, GE; Tunca, B | 1 |
| Bulanda, M; Jagielski, T; Skóra, M | 1 |
| Chowdhary, A; Curfs-Breuker, I; de Hoog, GS; Hagen, F; Madrid, H; Meis, JF | 1 |
| Bernal-Martínez, L; Cendejas, E; Forastiero, A; Gomez-Lopez, A; Mellado, E | 1 |
| Badali, H; Chowdhary, A; de Hoog, GS; Fakhim, H; Khodavaisy, S; Meis, JF | 1 |
| Bailly, S; Cornet, M; Gautier-Veyret, E; Maubon, D; Pelloux, H; Stanke-Labesque, F; Thiébaut-Bertrand, A; Tonini, J; Wambergue, C | 1 |
| Barrs, VR; Beatty, JA; Kidd, SE; Martin, P; Talbot, JJ | 1 |
| Albert, ND; Bellanger, AP; Kontoyiannis, DP; Lewis, RE; Walsh, TJ | 1 |
| Maertens, J; Miceli, MH | 1 |
| Gregg, KS; Kauffman, CA | 1 |
| Patterson, TF; Wiederhold, NP | 1 |
| Thompson, GR; Twarog, M | 1 |
| Chowdhary, A; Hagen, F; Kathuria, S; Meis, JF; Singh, PK | 1 |
| Capilla, J; Fothergill, AW; Guarro, J; Sanchis, M; Sutton, DA; Wiederhold, N | 1 |
| Coste, AT; Sanglard, D | 1 |
| Aftab, M; Almanfi, A; El-Sayed Ahmed, MM; Frazier, OH; Mallidi, HR; Singh, SK | 1 |
| Chai, LY; Khoo, AL; Lim, BP; Ong, B; Tan, BH; Tan, G; Tee, C; Teng, M; Zhao, YJ | 1 |
| Dehghan, P; Hashemi, SJ; Melchers, WJ; Mohammadi, F; Rafati, H; Rezaie, S; Seyedmousavi, S; Tamadon, Y; Tolooe, A; van der Lee, HA; Verweij, PE; Zoll, J | 1 |
| Arendrup, MC; Cuenca-Estrella, M; Jensen, RH | 1 |
| Cogliati, M; De Lorenzis, G; Esposto, MC; Lazzarini, C; Prigitano, A; Tortorano, AM | 1 |
| Manavathu, EK; Vazquez, JA | 1 |
| Fosso, MY; Garneau-Tsodikova, S; Shrestha, SK | 1 |
| Gökbolat, E; Ilkit, M; Kiraz, N; Öz, Y; Özdemir, HG; Seyedmousavi, S | 1 |
| Badali, H; Dolatabadi, S; Fakhim, H; Mirhendi, H; Nabili, M; Poorzad, N; Vaezi, A; Zarei, F | 1 |
| Molinelli, AR; Rose, CH | 1 |
| Capilla, J; Guarro, J; Mayayo, E; Paredes, K | 1 |
| Altamirano, R; Córdoba, S; Davel, G; Isla, MG; Szusz, W; Vivot, W | 1 |
| Aala, F; Amirizad, K; Aslani, N; Badali, H; Hashemi, SJ; Khodavaisy, S; Nazeri, M; Nouripour-Sisakht, S; Rezaie, S; Sorkherizi, MS | 1 |
| Ding, X; Gao, L; Liu, Z; Sun, Y; Wu, Q; Zeng, T | 1 |
| Lanternier, FL; Lortholary, O; Pilmis, B | 1 |
| Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Koenderink, JB; Lempers, VJ; Russel, FG; van den Heuvel, JJ | 1 |
| Andes, D; Azie, N; Franks, B; Harrington, R; Kelley, C; Khandelwal, N; Kristy, R; Lee, E; Spalding, J; Tan, RD; Wu, EQ; Yang, H | 1 |
| Jacobsen, AA; Papo, YB; Sarro, R; Strasswimmer, J; Weisse, K | 1 |
| Chakrabarti, A; Ghosh, A; Honnavar, P; Pamidi, U; Rastogi, V; Rudramurthy, SM | 1 |
| Augustynowicz-Kopeć, E; Garczewska, B; Jarzynka, S; Kuś, J; Skorupa, W | 1 |
| Arslan, U; Dagi, HT; Findik, D; Senkeles, C | 1 |
| Garneau-Tsodikova, S; Ngo, HX; Shrestha, SK | 1 |
| Chung, SJ; Hwang, WY; Tan, AL; Tan, BH; Tan, TT; Thien, SY | 1 |
| Backman, JT; Fihlman, M; Hagelberg, NM; Hemmilä, T; Kuusniemi, K; Laine, K; Laitila, J; Neuvonen, PJ; Olkkola, KT; Saari, TI | 1 |
| Barrueta, JA; Bow, EJ; Charbonneau, C; Cordonnier, C; Cornely, OA; Cragin, L; De Salas-Cansado, M; Garcia-Vidal, C; Jarque, I; Marks, DI; Pagliuca, A; Peral, C; Shaul, AJ; Slavin, M; Solano, C; Sorensen, S; Vanness, DJ | 1 |
| Bader, O; Buname, G; Groß, U; Mshana, SE; Mushi, MF | 1 |
| Akiti, T; Barreiros, G; Nouér, SA; Nucci, M; Trope, BM; Varon, AG | 1 |
| Bouza, E; Escribano, P; Guinea, J; Montilla, P; Muñoz, P; Padilla, B | 1 |
| Al-Hatmi, AM; de Hoog, GS; Meis, JF; Meletiadis, J; Normand, AC; Piarroux, R; Ranque, S | 1 |
| Basu, SS; Jarolim, P; Mason, DS; Petrides, A | 1 |
| Ahmed, SA; Behrens-Baumann, W; de Hoog, GS; Harak, H; Hofmüller, W; Seibold, M; Tammer, I; van Diepeningen, AD | 1 |
| Guo, H; Jiang, L; Li, DM; Li, SX; Song, YJ; Zhang, H; Zhao, YJ; Zhu, KJ | 1 |
| Annaert, P; Bouwsma, H; Hilbrands, L; Kuypers, DRJ; Spriet, I; Swen, JJ; Vanaudenaerde, B; Vanhove, T; Verleden, G; Vos, R | 1 |
| Alkhazraji, S; Baldin, C; Gebremariam, T; Ibrahim, AS; Kovanda, L; Wiederhold, NP | 1 |
| Behr, J; Ceelen, F; Ihle, F; Kneidinger, N; Matthes, S; Neurohr, C; Schramm, R; Stelzer, D; Vogeser, M; Weber, A; Winter, H; Zimmermann, G; Zoller, M | 1 |
| Bateman, AC; Clarridge, J; Garvin, K; Greenbaum, A; Grim, J; Liu, AW | 1 |
| Chen, F; Feng, CL; He, Q; Shi, Y; Su, X; Zhang, M | 1 |
| Crusz, SA; Denning, D; Mitchell, S; Simmonds, L; White, B | 1 |
| Birch, M; Law, D; Wiederhold, NP | 1 |
| Liu, Q; Marks, DI; Slavin, M | 1 |
| Hope, WW; Stott, KE | 1 |
| Arthur, I; Baird, R; Bak, N; Blyth, C; Botes, J; Chapman, B; Chen, S; Cheong, E; Cooley, L; George, CR; Goeman, E; Hajkowicz, K; Halliday, C; Heath, CH; Hofmeyr, A; Kalukottege, P; Keighley, C; Kennedy, K; Kesson, A; Kidd, S; Korman, TM; Leung, M; Liu, E; Macesic, N; Marriott, D; McMullan, B; Morrissey, CO; Pendle, S; Robson, J; Slavin, M; Sorrell, TC; Underwood, N; van Hal, S; Weeks, K | 1 |
| Ivulich, S; Jeong, W; Kong, DCM; Levvey, BJ; Morrissey, CO; Neoh, CF; Slavin, MA; Snell, GI; Westall, GP | 1 |
| Albert, ND; Heo, ST; Jiang, Y; Jiménez-Ortigosa, C; Kontoyiannis, DP; Lewis, RE; Meis, JF; Mikos, AG; Perlin, DS; Tarrand, J; Tatara, AM; Tverdek, F; Verweij, PE | 1 |
| D'Inzeo, T; De Carolis, E; Mello, E; Posteraro, B; Sanguinetti, M; Torelli, R; Vella, A; Verweij, PE | 1 |
| Agurto, C; Bustamante, B; Diaz, A; Hidalgo, J; Huaroto, L; Illescas, R; Ramirez, R; Rodriguez, L | 1 |
| Assaf, A; Chaftari, AM; Hachem, R; Jiang, Y; Numan, Y; Raad, II; Shah, P | 1 |
| Blaich, C; Gehlen, D; Liss, B; Müller, C; Prozeller, D; Streichert, T; Wiesen, MHJ | 1 |
| Bader, O; Baretton, G; Buchheidt, D; Geibel, S; Groß, U; Jacobs, E; Ostrosky-Zeichner, L; Rößler, S; Sommer, U; Spiess, B; Stölzel, F | 1 |
| Gao, L; Lu, Q; Sun, Y; Tian, D; Xiang, S | 1 |
| Bertaccini, P; Castagnetti, F; Cavo, M; Faccioli, L; Lewis, RE; Paolucci, M; Primavera, L; Rizzello, I; Spinardi, L; Stanzani, M; Toschi, PG | 1 |
| Fish, DN; Jaeger, J; Kiser, TH; MacLaren, R; Mueller, SW; Schoeppler, KE; Yi, WM | 1 |
| Gao, L; He, C; Li, M; Sun, Y; Zeng, T | 1 |
| Box, H; Colombo, AL; Hope, WW; Johnson, A; Kolamunnage-Dona, R; Livermore, J; McEntee, L; Negri, CE; Ramos-Martín, V; Schwartz, JA; Whalley, S | 1 |
| Byun, SA; Choi, MJ; Jung, JS; Kim, SH; Park, YJ; Shin, JH; Shin, MG; Suh, SP; Won, EJ | 1 |
| Brüggemann, RJM; Buil, JB; Meis, JF; Melchers, WJG; Mouton, JW; Verweij, PE; Wasmann, RE; Zoll, J | 1 |
| Hoenigl, M; Krause, R; Neumeister, P; Prattes, J; Wölfler, A | 1 |
| Foolad, F; Kontoyiannis, DP | 1 |
| Badali, H; Badiee, P; Boekhout, T; Diba, K; Hossaini Nasab, A; Jafarian, H; Mirhendi, H; Moghadam, AG; Mohammadi, R; Najafzadeh, MJ; Shamsizadeh, A; Soltani, J | 1 |
| Alakel, N; Behre, G; Buchheidt, D; Christopeit, M; Cornely, OA; Hasenkamp, J; Kiehl, M; Koldehoff, M; Krause, SW; Lehners, N; Löhnert, AY; Maschmeyer, G; Mayer, K; Mellinghoff, SC; Ostermann, H; Panse, J; Penack, O; Ruhnke, M; Teschner, D; Ullmann, AJ; von Lilienfeld-Toal, M; Wolf, HH | 1 |
| Birkenbach, M; Faizer, R; Green, JS; Ustun, C; Wasko, JA | 1 |
| Ahangarkani, F; Aslani, N; Badali, H; Boekhout, T; Hagen, F; Kolecka, A; Meis, JF; Meyabadi, MF; Shokohi, T | 1 |
| Bader, O; Becker, K; Groß, U; Idelevich, EA | 1 |
| Bailleux, C; Gari-Toussaint, M; Gastaud, L; Hasseine, L; Martiano, D; Simon, L | 1 |
| Greene, M; Harris, B; Kuriakose, K; Nesbitt, WJ | 1 |
| Ader, F; Aguado, JM; Akova, M; Arendrup, MC; Arikan-Akdagli, S; Barnes, RA; Beigelman-Aubry, C; Blot, S; Bouza, E; Brüggemann, RJM; Buchheidt, D; Cadranel, J; Castagnola, E; Chakrabarti, A; Cornely, OA; Cuenca-Estrella, M; Denning, DW; Dimopoulos, G; Fortun, J; Gangneux, JP; Garbino, J; Groll, AH; Heinz, WJ; Herbrecht, R; Heussel, CP; Kibbler, CC; Klimko, N; Kullberg, BJ; Lagrou, K; Lange, C; Lass-Flörl, C; Lehrnbecher, T; Lewis, RE; Löffler, J; Lortholary, O; Maertens, J; Marchetti, O; Meis, JF; Munoz, P; Pagano, L; Ribaud, P; Richardson, M; Roilides, E; Ruhnke, M; Sanguinetti, M; Sheppard, DC; Sinkó, J; Skiada, A; Ullmann, AJ; Vehreschild, MJGT; Verweij, PE; Viscoli, C; Warris, A | 1 |
| Butterton, JR; Cho, CR; de Haes, JIU; Drexel, M; Hulskotte, EGJ; Hussaini, A; Iwamoto, M; Jordan, HR; Kantesaria, BS; Liu, F; Macha, S; Marshall, WL; McCrea, JB; Menzel, K; Tsai, C; van Schanke, A | 1 |
| Bartoszewicz, M; Król, J; Nawrot, U | 1 |
| Qiao, M; Qiu, HY; Sun, AN; Tang, L; Tang, XW; Wu, DP; Yang, XF; Zhang, L | 1 |
| Andes, D; Desai, A; Kitt, T; Kovanda, L; Walsh, TJ; Zhao, M | 1 |
| Alcazar-Fuoli, L; Bernal-Martínez, L; Gomez-Lopez, A | 1 |
| Lang, R; Minion, J; Skinner, S; Wong, A | 1 |
| Landsberg, D; Leung, M; Poinen, K; Wright, AJ | 1 |
| Bartizal, K; Daruwala, P; Locke, JB; Wiederhold, NP | 1 |
| Dowis, J; French, D; Smith, A | 1 |
| Keniya, MV; Monk, BC; Ruma, YN; Tyndall, JDA | 1 |
| Fleming, ME; Gordon, WT; Jessie, EM; Khan, M; Malone, DL; Murray, CK; Potter, BK; Rodriguez, CJ; Shackelford, SA; Tribble, DR | 1 |
| French, B; Mandell, K; Martinez, R | 1 |
| Ahuja, T; Cirrone, F; Papadopoulos, J; Phillips, K; Siegfried, J | 1 |
| Lehrnbecher, T; Schmidt, S; Schubert, R; Tramsen, L | 1 |
| Bandettini, R; Cavanna, C; Esposto, MC; Grancini, A; Lallitto, F; Lo Cascio, G; Mularoni, A; Ossi, C; Prigitano, A; Tejada, M; Tortorano, AM | 1 |
| Flowers, SA; Kelly, DE; Kelly, SL; Nishimoto, AT; Parker, JE; Price, CL; Rogers, PD; Warrilow, AG | 1 |
| Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E | 1 |
| Al-Hatmi, AM; Arastehfar, A; Bakhtiari, M; Boekhout, T; Daneshnia, F; Fang, W; Groenewald, M; Hagen, F; Liao, W; Pan, W; Sadati, SK; Sharifi-Mehr, H; Zomorodian, K | 1 |
| Daly, RC; Kennedy, CC; Pennington, KM; Peters, S; Razonable, RR; Scott, JP; Wylam, M | 1 |
| Evans, SL; Fish, DN; Kiser, TH; MacLaren, R; Mueller, SW; Van Matre, ET | 1 |
| Alflen, A; Aranda Lopez, P; Beckert, H; Radsak, MP; Ries, F; Schild, H; Teschner, D; Theobald, M | 1 |
| Colley, T; Daly, L; Ito, K; Kimura, G; Kizawa, Y; Nakaoki, T; Nishimoto, Y; Rapeport, G; Sehra, G; Strong, P | 1 |
| Andes, DR; Bayless, M; Lepak, AJ; McCreary, EK; Schulz, LT; Van, AP; Wiebe, DA | 1 |
| Corcoran, TE; Ensor, CR; Hussain, S; Iasella, CJ; McDyer, JF; Moore, CA; Morrell, MR; Nero, JA; Nguyen, MH; Thanukrishnan, H; Venkataramanan, R | 1 |
| Braga, SS | 1 |
| Li, R; Sun, L; Wan, Z; Yu, J | 1 |
| Arbona-Haddad, E; Bold, TD; Chen, K; Cheng, MP; Cummins, KC; Hammond, SP; Koo, S; Kusztos, AE; Liakos, A; Marty, FM; Orejas, JL; Pandit, A; Solomon, IH | 1 |
| Elgierari, ETM; Kirkpatrick, LM; Manicke, NE; Ren, GJ; Shi, RZ; Skaggs, CL; Sturmer, LR | 1 |
| Dobiáš, R; Hošková, L; Hubka, V; Jaworská, P; Kautznerová, D; Kubánek, M; Lysková, P; Mrázek, J; Němcová, D; Skružná, M; Sumerauerová, P; Vrbská, J; Žáčková, P | 1 |
| Erbaş, G; Kalkanci, A; Köktürk, N; Özkurt, ZN; Pepeler, MS; Tunçcan, ÖG; Yegin, ZA; Yildirim, Z; Yildiz, Ş | 1 |
| Kauffman, CA; Schwartz, IS | 1 |
| Li, H; Tu, B; Yin, G | 1 |
| Abou El-Alamin, MM; Aboul-Enein, HY; Atia, MA; Sultan, MA | 1 |
| Carvalhaes, CG; Castanheira, M; Messer, SA; Pfaller, MA | 1 |
| Agarwal, R; Dhooria, S; Muthu, V; Prasad, KT; Sehgal, IS | 1 |
| Arron, ST; Brownell, I; Cahoon, EK; Cowen, EW; D'Arcy, ME; Engels, EA; Hess, GP; Israni, AK; Pfeiffer, RM; Rivera, DR; Triplette, MA; Yanik, EL | 1 |
| Pea, F | 1 |
| Arendrup, MC; Friberg, N; Guinea, J; Kahlmeter, G; Mares, M; Meletiadis, J | 1 |
| Usayaporn, S; Vanichanan, J; Weeraphon, B | 1 |
| Brito Devoto, T; Carmona, M; Cuestas, ML; Formento, N; Gordó, M; Hermida-Alava, K; Luque, A; Sautua, F; Scandiani, M | 1 |
| Corallo, CE; Ivulich, SP; Kotecha, DS; Morrissey, O | 1 |
| Cheng, G; Huang, L; Li, T; Luo, X; Xue, X; Zhang, Y | 1 |
| Gharaghani, M; Taghipour, S; Zarei Mahmoudabadi, A | 1 |
| Ben-Ami, R; Diego Vélez, J; Grandhi, A; Haider, S; Han, S; Karthaus, M; Klimko, N; Koh, LP; Lee, DG; Maertens, JA; Motyl, MR; Ponce-de-León, A; Raad, I; Rahav, G; Ramírez Sánchez, IC; Sonet, A; Waskin, H; Zhou, J | 1 |
| Akbari, F; Deng, S; Houbraken, J; Najafzadeh, MJ; Naseri, A; Wang, X; Xu, X; Zhang, H; Zhao, R | 1 |
| Mammen, MD; Rupa, V; Sahni, RD; Varghese, GM | 1 |
| Eadie, K; Fahal, AH; Nyuykonge, B; van Amelsvoort, L; van de Sande, W; Verbon, A | 1 |
| Carvalhaes, CG; Castanheira, M; Messer, SA; Pfaller, MA; Rhomberg, PR | 1 |
| Couraud, S; Dannaoui, E; Déméautis, T; Devouassoux, G; Dupont, D; Durieu, I; Garnier, H; Kramer, R; Lina, B; Menotti, J; Persat, F; Rabodonirina, M; Reix, P; Sénéchal, A; Simon, L; Wallon, M | 1 |
| Hochstetler, LJ; Jones, SL; McKinzie, BP; Musick, KL; Norris, AM; Williams, FN | 1 |
| Gupta, AK; Talukder, M; Venkataraman, M | 1 |
| Gao, L; Sun, Y; Tan, L; Yang, J; Yao, Z; Zeng, T | 1 |
| Atas, U; Aydin Ersoy, M; Iltar, U; Salim, O; Turkoglu, EB; Yucel, OK | 1 |
| Cai, Y; Chen, A; He, J; Ju, C; Li, S; Lian, Q; Wei, L; Xie, H; Zhao, B; Zhou, S | 1 |
| Boyd, S; Mahmoudjafari, Z; Martin, GA; Perry, C; Scott, SA; Thomas, B; Thompson, J | 1 |
| Carvalhaes, CG; Castanheira, M; Pfaller, MA | 1 |
| Grandhi, A; Haider, S; Han, S; Klimko, N; Lee, DG; Maertens, JA; Ponce-de-León, A; Rahav, G; Ramirez-Sanchez, IC; Waskin, H; Winchell, GA; Wrishko, R | 1 |
| Chu, J; Tu, S; Wang, N; Xie, Z; Yang, L; Zhang, K | 1 |
| Bazydlo, L; Girton, M; Tomsig, J | 1 |
53 review(s) available for voriconazole and posaconazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy.
Topics: 14-alpha Demethylase Inhibitors; Antiprotozoal Agents; Azoles; Humans; Leishmania; Molecular Structure; Sterol 14-Demethylase | 2017 |
Tetrazole hybrids and their antifungal activities.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Mycoses; Pyridines; Pyrimidines; Quinolines; Structure-Activity Relationship; Tetrazoles | 2019 |
The search for new triazole antifungal agents.
Topics: Antifungal Agents; Drugs, Investigational; Humans; Pyrimidines; Triazoles; Voriconazole | 1997 |
[Present problems and future trend of antifungals for deep seated mycosis. Azole antifungal agents].
Topics: Animals; Antifungal Agents; Azoles; Dosage Forms; Drug Interactions; Drug Resistance, Microbial; Fungi; Humans; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1999 |
[Present status and future prospects of azole antifungal agents in Japan].
Topics: Antifungal Agents; Azoles; Cyclodextrins; Drug Design; Fluconazole; Forecasting; Itraconazole; Japan; Miconazole; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2002 |
Laboratory evaluation of new antifungal agents against rare and refractory mycoses.
Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Echinocandins; Fungi; Humans; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2002 |
New antifungal agents.
Topics: Administration, Oral; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Drug Approval; Echinocandins; Humans; Lipopeptides; Macrolides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2003 |
[Invasive aspergillosis: clinical manifestations and treatment].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Caspofungin; Dermatomycoses; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Immunologic Factors; Itraconazole; Lipopeptides; Neuroaspergillosis; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Respiratory Tract Infections; Triazoles; Voriconazole | 2003 |
Antifungal agents in children.
Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole | 2005 |
Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Pyrimidines; Randomized Controlled Trials as Topic; Thiazoles; Triazoles; Voriconazole | 2006 |
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Cryptococcosis; Echinocandins; Fever; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Changing epidemiology of rare mould infections: implications for therapy.
Topics: Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Fusarium; Humans; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Zygomycosis | 2007 |
Antifungal agents.
Topics: Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Half-Life; Humans; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2007 |
Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations.
Topics: Antifungal Agents; Drug Monitoring; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
Antifungal agents--clinical pharmacokinetics and drug interactions.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Echinocandins; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
Invasive candidiasis in the ICU: evidence based and on the edge of evidence.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Intensive Care Units; Itraconazole; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2008 |
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Prevention of mould infections.
Topics: Antifungal Agents; Chemoprevention; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Mycoses; Neutropenia; Patient Isolation; Pyrimidines; Triazoles; Voriconazole | 2009 |
Diagnosis and treatment of aspergillosis in children.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Echinocandins; Fungal Vaccines; Genomics; Humans; Immunocompromised Host; Lipopeptides; Micafungin; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2009 |
In vitro activity of antifungals against Zygomycetes.
Topics: Amphotericin B; Antifungal Agents; Echinocandins; Humans; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
Onychomycosis.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2010 |
Traditional and emerging antifungal therapies.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole | 2010 |
Conazoles.
Topics: Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Miconazole; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole | 2010 |
Therapeutic drug monitoring of voriconazole and posaconazole.
Topics: Antifungal Agents; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Humans; Pyrimidines; Triazoles; Voriconazole | 2011 |
Pharmacology and metabolism of voriconazole and Posaconazole in the treatment of invasive aspergillosis: review of the literature.
Topics: Antifungal Agents; Drug Interactions; Humans; Invasive Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2011 |
Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Therapy, Combination; Echinocandins; Evidence-Based Medicine; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2011 |
Triazole antifungal agents in invasive fungal infections: a comparative review.
Topics: Antifungal Agents; Fluconazole; Fungi; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Endophthalmitis caused by Phialophora verrucosa: a case report and literature review of Phialophora ocular infections.
Topics: Aged; Amphotericin B; Antifungal Agents; Caspofungin; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Glaucoma; Humans; Hypertension; Intravitreal Injections; Lipopeptides; Male; Phialophora; Pyrimidines; Triazoles; Vitrectomy; Voriconazole | 2012 |
[Azole resistance in Aspergillus fumigatus in the Netherlands--increase due to environmental fungicides?].
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Environmental Microbiology; Fungicides, Industrial; Humans; Itraconazole; Microbial Sensitivity Tests; Netherlands; Pyrimidines; Triazoles; Voriconazole | 2012 |
Neuro-ophthalmology of invasive fungal sinusitis: 14 consecutive patients and a review of the literature.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Cause of Death; Eye Infections, Fungal; Female; Fungi; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Risk Factors; Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Pharmacoeconomic assessment of therapy for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Cost-Benefit Analysis; Empirical Research; Humans; Length of Stay; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Old and new: appropriate dosing for neonatal antifungal drugs in the nursery.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Combinations; Echinocandins; Fluconazole; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Neonatology; Pyrimidines; Triazoles; Voriconazole | 2013 |
Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Clinical Trials as Topic; Drug Administration Schedule; Drug Dosage Calculations; Drug Monitoring; Drug Resistance, Fungal; Humans; Pyrimidines; Triazoles; Voriconazole | 2013 |
Clinically relevant drug-drug interactions between antiretrovirals and antifungals.
Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-Retroviral Agents; Antifungal Agents; Benzoxazines; Carbamates; Cyclopropanes; Drug Interactions; Drug Monitoring; Echinocandins; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Itraconazole; Mycoses; Organophosphates; Pyrimidines; Ritonavir; Sulfonamides; Triazoles; Voriconazole | 2014 |
Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cholesterol; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole | 2014 |
The role of azoles in the management of azole-resistant aspergillosis: from the bench to the bedside.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Models, Biological; Mutation; Translational Research, Biomedical; Triazoles; Voriconazole | 2014 |
Optimizing azole antifungal therapy in the prophylaxis and treatment of fungal infections.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Itraconazole; Mycoses; Population Surveillance; Precision Medicine; Triazoles; Voriconazole | 2014 |
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014.
Topics: Antifungal Agents; Consensus; Drug Administration Schedule; Drug Delivery Systems; Drug Dosage Calculations; Drug Interactions; Drug Monitoring; Hematologic Neoplasms; Humans; Molecular Sequence Data; Mycoses; Opportunistic Infections; Practice Guidelines as Topic; Rehydration Solutions; Triazoles; Voriconazole | 2014 |
Role of Non-Culture-Based Tests, with an Emphasis on Galactomannan Testing for the Diagnosis of Invasive Aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Bronchoalveolar Lavage Fluid; Galactose; Humans; Mannans; Proteoglycans; Triazoles; Voriconazole | 2015 |
Invasive Aspergillosis: Epidemiology, Clinical Aspects, and Treatment.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Drug Therapy, Combination; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lung Transplantation; Magnetic Resonance Imaging; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2015 |
Emergence of Azole Resistance in Aspergillus.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Humans; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole | 2015 |
Coccidioidomycosis: Recent Updates.
Topics: Antifungal Agents; Coccidioides; Coccidioidomycosis; Humans; Nitriles; Pneumonia; Pyridines; Risk Factors; Triazoles; Voriconazole | 2015 |
Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis.
Topics: Adult; Antifungal Agents; Aspergillus; Candida; Cost-Benefit Analysis; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Economic; Mycoses; Singapore; Survival Analysis; Triazoles; Voriconazole | 2016 |
Voriconazole for prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplantation.
Topics: Antifungal Agents; Cost-Benefit Analysis; Drug Administration Schedule; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Practice Guidelines as Topic; Primary Prevention; Transplantation, Homologous; Triazoles; Voriconazole | 2017 |
Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations.
Topics: Antifungal Agents; Biological Availability; Drug Monitoring; Fungi; Humans; Invasive Fungal Infections; Itraconazole; Nitriles; Pyridines; Triazoles; Voriconazole | 2017 |
Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia.
Topics: Amphotericin B; Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Endophthalmitis; Female; Fungemia; Fusariosis; Fusarium; Humans; Immunocompromised Host; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2018 |
Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
Topics: Antifungal Agents; Clinical Trials as Topic; Drug Monitoring; Hematology; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Induction Chemotherapy; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Medical Oncology; Myelodysplastic Syndromes; Primary Prevention; Societies, Medical; Triazoles; Voriconazole | 2018 |
Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing.
Topics: Amphotericin B; Antifungal Agents; Drug Repositioning; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leishmaniasis; Molecular Targeted Therapy; Phosphorylcholine; Sterol 14-Demethylase; Triazoles; Voriconazole | 2019 |
Blastomycosis.
Topics: Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Humans; Immunocompromised Host; Itraconazole; Triazoles; Voriconazole | 2020 |
An overview of the available treatments for chronic cavitary pulmonary aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Disease Management; Echinocandins; Humans; Itraconazole; Nitriles; Practice Guidelines as Topic; Pulmonary Aspergillosis; Pyridines; Triazoles; Voriconazole | 2020 |
From bench to bedside: Perspectives on the utility of pharmacokinetics/pharmacodynamics in predicting the efficacy of antifungals in invasive candidiasis.
Topics: Amphotericin B; Animals; Antifungal Agents; Antimicrobial Stewardship; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidiasis, Invasive; Echinocandins; Fluconazole; Flucytosine; Humans; Species Specificity; Triazoles; Voriconazole | 2020 |
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST).
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Practice Guidelines as Topic; Triazoles; Voriconazole | 2020 |
Review of the alternative therapies for onychomycosis and superficial fungal infections: posaconazole, fosravuconazole, voriconazole, oteseconazole.
Topics: Antifungal Agents; Complementary Therapies; Dermatologic Agents; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome; Voriconazole | 2022 |
6 trial(s) available for voriconazole and posaconazole
| Article | Year |
|---|---|
Intracellular concentrations of posaconazole in different compartments of peripheral blood.
Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Erythrocytes; Female; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Neutrophils; Triazoles | 2010 |
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction.
Topics: Administration, Sublingual; Adult; Analgesics, Opioid; Antifungal Agents; Buprenorphine; Cross-Over Studies; Cytochrome P-450 Enzyme System; Drug Interactions; Healthy Volunteers; Humans; Male; Pain; Single-Blind Method; Triazoles; Voriconazole; Young Adult | 2016 |
Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects.
Topics: Acetates; Administration, Oral; Adult; Antifungal Agents; Antiviral Agents; Area Under Curve; Drug Combinations; Drug Interactions; Female; Healthy Volunteers; Humans; Middle Aged; Quinazolines; Triazoles; Voriconazole | 2018 |
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Antifungal Agents; Double-Blind Method; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prospective Studies; Triazoles; Voriconazole; Young Adult | 2021 |
Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis.
Topics: Aspergillosis; Double-Blind Method; Humans; Triazoles; Voriconazole | 2023 |
354 other study(ies) available for voriconazole and posaconazole
| Article | Year |
|---|---|
Posaconazole enhances the activity of amphotericin B against Aspergillus hyphae in vitro.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2007 |
In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest.
Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Quality Control; Zygomycosis | 2007 |
A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genotype; Humans; Microbial Sensitivity Tests; Tandem Repeat Sequences | 2007 |
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
In vitro susceptibility to posaconazole of 1,903 yeast isolates recovered in France from 2003 to 2006 and tested by the method of the European committee on antimicrobial susceptibility testing.
Topics: Antifungal Agents; Fluconazole; France; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2007 |
Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms.
Topics: Antifungal Agents; Azoles; Biofilms; Candida; Candida albicans; Echinocandins; Humans; Microbial Sensitivity Tests | 2008 |
In vitro antifungal susceptibilities of five species of sporothrix.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Specificity; Sporothrix; Sporotrichosis | 2008 |
Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification.
Topics: Antifungal Agents; Aspergillus fumigatus; Fungal Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Nuclear Proteins; Phylogeny; Polymerase Chain Reaction; Sequence Analysis, DNA; Tubulin | 2008 |
In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba.
Topics: Antifungal Agents; Azoles; Cryptococcosis; Cryptococcus neoformans; Cuba; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles | 2008 |
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.
Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity | 2008 |
In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Fusarium; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Naphthalenes; Sequence Analysis, DNA; Terbinafine; Triazoles; Tubulin | 2008 |
Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy.
Topics: Antifungal Agents; Base Sequence; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Fusarium; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Species Specificity | 2008 |
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.
Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2008 |
Susceptibility testing and molecular classification of Paecilomyces spp.
Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; Echinocandins; Itraconazole; Microbial Sensitivity Tests; Paecilomyces; Phylogeny | 2008 |
Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Europe; Fungi; Guidelines as Topic; Humans; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Triazoles; Yeasts | 2008 |
Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biofilms; Bronchi; Cells, Cultured; Cystic Fibrosis; Drug Resistance, Fungal; Epithelial Cells; Humans; Microbial Sensitivity Tests; Microscopy, Confocal; Microscopy, Electron, Scanning; Respiratory Tract Infections | 2008 |
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged | 2008 |
Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans.
Topics: Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Fluconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Serotyping; Triazoles; Voriconazole | 2009 |
In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; DNA, Fungal; Humans; Microbial Sensitivity Tests; Soil Microbiology | 2009 |
Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Humans; Immunohistochemistry; Injections, Intraperitoneal; Lipopeptides; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2009 |
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece.
Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies | 2009 |
In vitro activity of Isavuconazole against Aspergillus species and zygomycetes according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
Topics: Antifungal Agents; Aspergillus; Microbial Sensitivity Tests; Mucorales; Nitriles; Pyridines; Triazoles | 2009 |
Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers.
Topics: Amphotericin B; Antifungal Agents; DNA, Ribosomal Spacer; Microbial Sensitivity Tests; Mucorales; Triazoles | 2009 |
Interactions between triazoles and amphotericin B in treatment of disseminated murine infection by Fusarium oxysporum.
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy, Combination; Fusarium; Male; Mice; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Penicillium; Scedosporium; Spain | 2009 |
Simultaneous determination of voriconazole and posaconazole concentrations in human plasma by high-performance liquid chromatography.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2009 |
Efficacy of triazoles in a murine disseminated infection by Candida krusei.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Kidney; Male; Mice; Pyrimidines; Random Allocation; Triazoles; Voriconazole | 2009 |
Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri.
Topics: Antifungal Agents; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny | 2009 |
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy.
Topics: Aged; Antifungal Agents; Echinocandins; Fatal Outcome; Geotrichosis; Geotrichum; Humans; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Neutropenia | 2009 |
Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Kidney; Male; Mice; Mucormycosis; Rhizopus; Triazoles | 2009 |
In vitro activity of thimerosal against ocular pathogenic fungi.
Topics: Alternaria; Amphotericin B; Antifungal Agents; Aspergillus; Eye Infections, Fungal; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Natamycin; Thimerosal | 2010 |
Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene.
Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disease Models, Animal; Drug Administration Schedule; Female; Fungal Proteins; Mice; Microbial Sensitivity Tests; Mutation; Triazoles | 2010 |
In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2010 |
Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection.
Topics: Animals; Antifungal Agents; Base Sequence; Candida albicans; Candidiasis; Disease Models, Animal; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Female; Fluconazole; Fungal Proteins; Genes, Fungal; Genetic Engineering; Humans; In Vitro Techniques; Membrane Transport Proteins; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation | 2010 |
Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genes, Fungal; Humans; In Vitro Techniques; Models, Molecular; Mutation, Missense; Protein Conformation; Structural Homology, Protein; Tandem Repeat Sequences | 2010 |
Antifungal susceptibility profile of human-pathogenic species of Lichtheimia.
Topics: Amphotericin B; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mucorales; Pyrimidines; Triazoles; Voriconazole | 2010 |
In vitro antifungal activities of bis(alkylpyridinium)alkane compounds against pathogenic yeasts and molds.
Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyridinium Compounds; Yeasts | 2010 |
Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma.
Topics: Antifungal Agents; Calibration; Chromatography, High Pressure Liquid; Humans; Itraconazole; Mass Spectrometry; Pyrimidines; Reference Standards; Triazoles; Voriconazole | 2010 |
Experimental murine scedosporiosis: histopathology and azole treatment.
Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Brain; Kidney; Mice; Mycetoma; Pyrimidines; Scedosporium; Spleen; Treatment Outcome; Triazoles; Voriconazole | 2010 |
In vitro antifungal activities of isavuconazole and comparators against rare yeast pathogens.
Topics: Antifungal Agents; Dipodascus; Fluconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Rhodotorula; Saccharomyces cerevisiae; Triazoles; Trichosporon; Voriconazole | 2010 |
Expression, purification, and characterization of Aspergillus fumigatus sterol 14-alpha demethylase (CYP51) isoenzymes A and B.
Topics: Amino Acid Sequence; Aspergillus fumigatus; Azoles; Clotrimazole; Drug Resistance, Multiple, Fungal; Fluconazole; Fungal Proteins; Isoenzymes; Itraconazole; Lanosterol; Molecular Sequence Data; Protein Binding; Pyrimidines; Sequence Homology, Amino Acid; Sterol 14-Demethylase; Substrate Specificity; Triazoles; Voriconazole | 2010 |
Complementation of a Saccharomyces cerevisiae ERG11/CYP51 (sterol 14α-demethylase) doxycycline-regulated mutant and screening of the azole sensitivity of Aspergillus fumigatus isoenzymes CYP51A and CYP51B.
Topics: Anti-Bacterial Agents; Aspergillus fumigatus; Azoles; Clotrimazole; Cytochrome P-450 Enzyme System; Doxycycline; Ergosterol; Fluconazole; Fungal Proteins; Genetic Complementation Test; Itraconazole; Pyrimidines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Triazoles; Voriconazole | 2010 |
In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella.
Topics: Amphotericin B; Animals; Antifungal Agents; Caspofungin; Cunninghamella; Diabetes Mellitus, Experimental; Echinocandins; Itraconazole; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2010 |
Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain.
Topics: Antifungal Agents; Aspergillus fumigatus; Austria; Azoles; Denmark; Drug Resistance, Fungal; Environmental Microbiology; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole | 2010 |
Synthesis and in vitro antimicrobial activities of new (cyano-NNO-azoxy)pyrazole derivatives.
Topics: Anti-Infective Agents; Antifungal Agents; Azo Compounds; Candida; Microbial Sensitivity Tests; Molecular Structure; Nitriles; Pyrazoles; Staphylococcus aureus | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Design and optimization of highly-selective fungal CYP51 inhibitors.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Candida albicans; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Conformation; Sterol 14-Demethylase; Structure-Activity Relationship | 2014 |
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
Topics: Antifungal Agents; Benzimidazoles; Carbon-13 Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Proton Magnetic Resonance Spectroscopy; Reactive Oxygen Species; Yeasts | 2016 |
Novel alkylated azoles as potent antifungals.
Topics: Alkylation; Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Cell Line; Ergosterol; Fungi; Hemolysis; Humans; Mice; Microbial Sensitivity Tests; Mycoses | 2017 |
Sterol 14α-Demethylase Structure-Based Design of VNI (( R)- N-(1-(2,4-Dichlorophenyl)-2-(1 H-imidazol-1-yl)ethyl)-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide)) Derivatives To Target Fungal Infections: Synthesis, Biological Evaluation, and Crystallographic
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Catalytic Domain; Chemistry Techniques, Synthetic; Crystallography, X-Ray; Drug Design; Imidazoles; Ligands; Models, Molecular; Sterol 14-Demethylase | 2018 |
Antifungal activity, mode of action variability, and subcellular distribution of coumarin-based antifungal azoles.
Topics: Antifungal Agents; Azoles; Candida; Cell Survival; Coumarins; Dose-Response Relationship, Drug; HEK293 Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Optical Imaging; Structure-Activity Relationship | 2019 |
New azole antifungals with a fused triazinone scaffold.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Mice; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazines | 2020 |
Identification of Thiazoyl Guanidine Derivatives as Novel Antifungal Agents Inhibiting Ergosterol Biosynthesis for Treatment of Invasive Fungal Infections.
Topics: Antifungal Agents; Aspergillus fumigatus; Dose-Response Relationship, Drug; Ergosterol; Guanidine; Humans; Invasive Fungal Infections; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Thiazoles | 2021 |
Relaxed Substrate Requirements of Sterol 14α-Demethylase from
Topics: 14-alpha Demethylase Inhibitors; Ligands; Naegleria fowleri; Sterol 14-Demethylase; Substrate Specificity | 2021 |
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; Genotype; HIV Infections; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth; North America; Pharynx; Phenotype; Pyrimidines; Triazoles; Voriconazole | 1998 |
[Antifungal drugs: the new frontier].
Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Caspofungin; Drug Resistance, Microbial; Echinocandins; Female; Fungi; Humans; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Research; Triazoles; Trypanocidal Agents; Voriconazole | 1998 |
In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazole.
Topics: Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1998 |
Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Itraconazole; Kinetics; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 1999 |
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1999 |
In vitro susceptibility of environmental Cryptococcus neoformans variety neoformans isolates from Turkey to six antifungal agents, including SCH56592 and voriconazole.
Topics: Animals; Antifungal Agents; Columbidae; Cryptococcus neoformans; Environmental Microbiology; Feces; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Turkey; Voriconazole | 2000 |
A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole | 2000 |
Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Microbial; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2001 |
In vitro activities of four novel triazoles against Scedosporium spp.
Topics: Antifungal Agents; Humans; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Scedosporium; Thiazoles; Triazoles; Voriconazole | 2001 |
Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2001 |
Azole cross-resistance in Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Microbial; Drug Resistance, Multiple; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2002 |
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Canada; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Quality Control; Thiazoles; Triazoles; United States; Voriconazole | 2002 |
Clinical evaluation of a frozen commercially prepared microdilution panel for antifungal susceptibility testing of seven antifungal agents, including the new triazoles posaconazole, ravuconazole, and voriconazole.
Topics: Antifungal Agents; Candida; Freezing; Humans; Microbial Sensitivity Tests; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2002 |
E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method.
Topics: Antifungal Agents; Aspergillus; Humans; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2002 |
Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum.
Topics: Adult; Antifungal Agents; Humans; Hyphae; Itraconazole; Neutrophils; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2002 |
In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients.
Topics: Antifungal Agents; Blood; Candida; Candidiasis; Echinocandins; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Neoplasms; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2002 |
Effect of medium composition on static and cidal activity of amphotericin B, itraconazole, voriconazole, posaconazole and terbinafine against Aspergillus fumigatus: a multicenter study.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Culture Media; France; Humans; Itraconazole; Laboratories; Microbial Sensitivity Tests; Naphthalenes; Observer Variation; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2002 |
In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results.
Topics: Antifungal Agents; Colony Count, Microbial; Culture Media; Fusarium; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2002 |
In vitro susceptibilities of cerebrospinal fluid isolates of Cryptococcus neoformans collected during a ten-year period against fluconazole, voriconazole and posaconazole (SCH56592).
Topics: Antifungal Agents; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2002 |
In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.
Topics: Antifungal Agents; Blood; Candida; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2003 |
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.
Topics: Amphotericin B; Anti-Bacterial Agents; Aspergillus; Caspofungin; Echinocandins; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Penicillium; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2003 |
[In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2003 |
In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program.
Topics: Candida; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Global Health; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multicenter Studies as Topic; Probability; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole | 2004 |
Alternatives to amphotericin B for Candida rugosa infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Colony Count, Microbial; Fluconazole; Kidney; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Organ Size; Pyrimidines; Spleen; Survival Analysis; Triazoles; Voriconazole | 2004 |
Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazole.
Topics: Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Thiazoles; Triazoles; Voriconazole | 2004 |
Effect of media composition and in vitro activity of posaconazole, caspofungin and voriconazole against zygomycetes.
Topics: Absidia; Antifungal Agents; Caspofungin; Culture Media; Cunninghamella; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Mucor; Mucorales; Peptides, Cyclic; Pyrimidines; Rhizopus; Triazoles; Voriconazole | 2005 |
In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi.
Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Species Specificity; Thiazoles; Triazoles; Voriconazole | 2005 |
International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.
Topics: Antifungal Agents; Candida; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2005 |
Lung infection due to opportunistic fungus, Phialemonium obovatum, in a bone marrow transplant recipient: an emerging infection with fungemia and Crohn disease-like involvement of the gastrointestinal tract.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Bone Marrow Transplantation; Drug Resistance, Fungal; Fungemia; Gastrointestinal Diseases; Graft vs Host Disease; Granuloma; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2005 |
Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Reproducibility of Results; Spectrophotometry; Triazoles; Voriconazole | 2005 |
Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Paecilomyces; Pyrimidines; Quality Control; Triazoles; Voriconazole | 2005 |
Advances in antifungal therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Animals; Antifungal Agents; Caspofungin; Child; Child, Preschool; Clinical Trials as Topic; Echinocandins; Fungal Proteins; Humans; Infant; Infant, Newborn; Lipopeptides; Lipoproteins; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Thiazoles; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emerging; Dermatomycoses; Disease Susceptibility; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Sinusitis; Transplantation Conditioning; Triazoles; Viscera; Voriconazole | 2005 |
Autologous transplantation of CD133 selected hematopoietic progenitor cells for treatment of relapsed acute lymphoblastic leukemia.
Topics: AC133 Antigen; Amphotericin B; Antifungal Agents; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Caspofungin; Child; Combined Modality Therapy; Contraindications; Dexamethasone; Drug Therapy, Combination; Echinocandins; Glycoproteins; Humans; Immunomagnetic Separation; Lipopeptides; Male; Mercaptopurine; Methotrexate; Peptides; Peptides, Cyclic; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Vincristine; Voriconazole; Zygomycosis | 2007 |
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts | 2006 |
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cryptococcosis; Cryptococcus; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Resistance, Multiple, Fungal; Drug Synergism; Echinocandins; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Peptides, Cyclic; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2006 |
Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Bone Marrow Transplantation; Cefepime; Cephalosporins; Combined Modality Therapy; Cunninghamella; Daunorubicin; Drug Resistance, Multiple, Fungal; Female; Humans; Imatinib Mesylate; Immunocompromised Host; Lung Diseases, Fungal; Middle Aged; Neutropenia; Piperazines; Pneumonectomy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Transplantation Conditioning; Triazoles; Vancomycin; Vincristine; Voriconazole; Zygomycosis | 2006 |
Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp.
Topics: Antifungal Agents; Aspergillus; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2006 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
Multi-azole resistance in Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Itraconazole; Lipopeptides; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2006 |
Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Culture Media; Disk Diffusion Antimicrobial Tests; Echinocandins; Fungi; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2007 |
Successful treatment and limb salvage of mucor necrotizing fasciitis after kidney transplantation with posaconazole.
Topics: Alcaligenes; Amphotericin B; Amputation, Surgical; Antifungal Agents; Cefazolin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Drug Resistance, Multiple, Fungal; Escherichia coli Infections; Fatal Outcome; Fluconazole; Gangrene; Graft Rejection; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg; Leg Ulcer; Male; Middle Aged; Mucor; Mucormycosis; Penicillanic Acid; Phosphatidylcholines; Phosphatidylglycerols; Piperacillin; Postoperative Complications; Pyrimidines; Renal Dialysis; Reoperation; Sepsis; Skin Transplantation; Tazobactam; Triazoles; Voriconazole | 2007 |
Inherited long QT syndrome revealed by antifungals drug-drug interaction.
Topics: Acute Disease; Adolescent; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Female; Genotype; Humans; Injections, Intravenous; Leukemia, Myeloid; Long QT Syndrome; Mixed Function Oxygenases; Mucormycosis; Pyrimidines; Torsades de Pointes; Triazoles; Voriconazole | 2007 |
[Correlations among itraconazole, voriconazole and posaconazole MICs in Aspergillus fumigatus].
Topics: Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2007 |
Posaconazole prophylaxis in hematologic cancer.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Humans; Mucositis; Mycoses; Opportunistic Infections; Oxidoreductases; Point Mutation; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole | 2007 |
Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Corneal Ulcer; Echinocandins; Eye Infections, Fungal; Fusarium; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Natamycin; Peptides, Cyclic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2007 |
Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.
Topics: Aged; Amphotericin B; Antifungal Agents; Cross Infection; Drug Therapy, Combination; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2007 |
Lack of cross-hepatotoxicity between voriconazole and posaconazole.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chemical and Drug Induced Liver Injury; Humans; Pyrimidines; Triazoles; Voriconazole | 2007 |
Recalcitrant Beauveria bassiana keratitis: confocal microscopy findings and treatment with posaconazole (Noxafil).
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Beauveria; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Microscopy, Confocal; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida spp.: results from a global antifungal surveillance program.
Topics: Antifungal Agents; Biomarkers; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Regression Analysis; Triazoles; Voriconazole | 2008 |
Multilaboratory testing of antifungal combinations against a quality control isolate of Candida krusei.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Laboratories; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Triazoles; Voriconazole | 2008 |
Interaction of amphotericin B lipid formulations and triazoles with human polymorphonuclear leucocytes for antifungal activity against Zygomycetes.
Topics: Absidia; Adult; Amphotericin B; Antifungal Agents; Drug Combinations; Drug Interactions; Humans; Hyphae; Liposomes; Microbial Sensitivity Tests; Neutrophils; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Rhizopus; Triazoles; Voriconazole | 2008 |
MICs and minimum fungicidal concentrations of posaconazole, voriconazole and fluconazole for Cryptococcus neoformans and Cryptococcus gattii.
Topics: Animals; Antifungal Agents; Bird Diseases; Columbidae; Cryptococcosis; Cryptococcus; Fluconazole; Humans; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Triazoles; Voriconazole | 2008 |
[New systemic antifungal drugs].
Topics: Antifungal Agents; Humans; Pyrimidines; Triazoles; Voriconazole | 2008 |
Rhino-cerebral zygomycosis resistant to antimycotic treatment: a case report.
Topics: Aged; Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Central Nervous System Diseases; Drug Resistance, Fungal; Fatal Outcome; Humans; Male; Methylprednisolone; Purpura, Thrombocytopenic, Idiopathic; Pyrimidines; Rhinitis; Rhizopus; Triazoles; Voriconazole; Zygomycosis | 2009 |
Breakthrough disseminated Scedosporium prolificans infection in a patient with relapsed leukaemia on prolonged voriconazole followed by posaconazole prophylaxis.
Topics: Administration, Oral; Antifungal Agents; Antineoplastic Agents; Fatal Outcome; Humans; Leukemia; Male; Middle Aged; Mycetoma; Opportunistic Infections; Pyrimidines; Recurrence; Scedosporium; Triazoles; Voriconazole | 2008 |
Does pre-exposure of Aspergillus fumigatus to voriconazole or posaconazole in vitro affect its virulence and the in vivo activity of subsequent posaconazole or voriconazole, respectively? A study in a fly model of aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drosophila melanogaster; Drosophila Proteins; Pyrimidines; Survival Analysis; Toll-Like Receptors; Triazoles; Virulence; Voriconazole | 2008 |
Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fluconazole; Humans; Infant; Infant, Newborn; Itraconazole; Lipopeptides; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Thiazoles; Triazoles; Voriconazole; Young Adult | 2008 |
Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Azoles; Cryptococcus; Culture Media; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
Comparison of posaconazole and voriconazole in vitro killing against Candida krusei.
Topics: Antifungal Agents; Candida; Candidiasis; Culture Media; Drug Resistance, Fungal; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2008 |
In vitro susceptibility of Pythium insidiosum and a Lagenidium sp to itraconazole, posaconazole, voriconazole, terbinafine, caspofungin, and mefenoxam.
Topics: Alanine; Anti-Infective Agents; Caspofungin; Echinocandins; In Vitro Techniques; Itraconazole; Lagenidium; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Pythium; Terbinafine; Triazoles; Voriconazole | 2008 |
Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Resistance, Multiple, Fungal; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2008 |
International interlaboratory proficiency testing program for measurement of azole antifungal plasma concentrations.
Topics: Antifungal Agents; Azoles; Biological Assay; Fluconazole; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2009 |
Adverse drug events complicate antifungal therapy for pulmonary aspergilloma.
Topics: Aged; Antifungal Agents; Aspergillosis; Drug Interactions; Follow-Up Studies; Hallucinations; Heart Failure; Humans; Itraconazole; Liver Function Tests; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 2008 |
Voriconazole and posaconazole resistant Candida pelliculosa fungemia after cardiac surgery.
Topics: Amphotericin B; Antifungal Agents; Candida; Cardiac Surgical Procedures; Child; Drug Resistance, Multiple, Fungal; Fungemia; Humans; Infant; Postoperative Complications; Pyrimidines; Triazoles; Voriconazole | 2009 |
Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Exophiala; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Synergism; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Rhizopus; Triazoles; Voriconazole | 2008 |
Safe management of tacrolimus together with posaconazole in lung transplant patients with cystic fibrosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Cystic Fibrosis; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Female; Graft Rejection; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Microbial Sensitivity Tests; Mycoses; Prescriptions; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2009 |
Dynamics of in vitro acquisition of resistance by Candida parapsilosis to different azoles.
Topics: Antifungal Agents; Biosynthetic Pathways; Candida; Drug Resistance, Fungal; Ergosterol; Fluconazole; Humans; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole | 2009 |
[Painful peripheral neuropathy associated with voriconazole during the treatment of chronic cavitary pulmonary aspergillosis].
Topics: Aged; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Chronic Disease; Humans; Male; Pain; Peripheral Nervous System Diseases; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Management of metabolic cytochrome P450 3A4 drug-drug interaction between everolimus and azole antifungals in a renal transplant patient.
Topics: Antifungal Agents; Aspergillosis; Cytochrome P-450 CYP3A; Drug Interactions; Drug Monitoring; Everolimus; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pyrimidines; Sirolimus; Triazoles; Voriconazole | 2009 |
Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection.
Topics: Calibration; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Stability; Fluconazole; Humans; Itraconazole; Ketoconazole; Pyrimidines; Quality Control; Reproducibility of Results; Spectrophotometry, Ultraviolet; Time Factors; Triazoles; Ultraviolet Rays; Voriconazole | 2009 |
Atypical Aspergillus flavus isolates associated with chronic azole therapy.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Azoles; Female; Humans; Itraconazole; Middle Aged; Pyrimidines; Sinusitis; Triazoles; Voriconazole | 2009 |
Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis.
Topics: Adult; Amino Acid Substitution; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Azoles; Bronchitis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Middle Aged; Mutation, Missense; Plasma; Pyrimidines; Triazoles; Voriconazole | 2010 |
Evaluation of antifungal therapy in a neutropenic murine model of Neoscytalidium dimidiatum infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Colony Count, Microbial; Disease Models, Animal; Kidney; Male; Mice; Mycoses; Neutropenia; Pyrimidines; Sepsis; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Current controversies in treating invasive zygomycosis.
Topics: Amphotericin B; Antifungal Agents; Cunninghamella; Drug Therapy, Combination; Humans; Lung Diseases, Fungal; Mucormycosis; Pyrimidines; Triazoles; Voriconazole | 2010 |
Cunninghamella bertholletiae exhibits increased resistance to human neutrophils with or without antifungal agents as compared to Rhizopus spp.
Topics: Adult; Antifungal Agents; Caspofungin; Cells, Cultured; Cunninghamella; Echinocandins; Enzyme-Linked Immunosorbent Assay; Humans; Interleukin-6; Interleukin-8; Lipopeptides; Microbial Viability; Neutrophils; Pyrimidines; Rhizopus; Tetrazolium Salts; Triazoles; Tumor Necrosis Factor-alpha; Voriconazole | 2010 |
Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Australia; Chemoprevention; Cost-Benefit Analysis; Female; Hospitals; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2010 |
AfMkk2 is required for cell wall integrity signaling, adhesion, and full virulence of the human pathogen Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cell Adhesion; Cell Wall; Disease Models, Animal; Glass; Humans; Hydrogen-Ion Concentration; Mice; Mitogen-Activated Protein Kinase Kinases; Plastics; Pyrimidines; Signal Transduction; Survival Analysis; Temperature; Triazoles; Virulence; Virulence Factors; Voriconazole | 2010 |
In vitro susceptibility of filamentous fungi to itraconazole, voriconazole and posaconazole by Clinical and Laboratory Standards Institute reference method and E-test.
Topics: Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Europe; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; United States; Voriconazole | 2010 |
Aspergillus endocarditis 2003-2009.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Child; Child, Preschool; Endocarditis; Humans; Immunocompromised Host; Infant; Male; Middle Aged; Pyrimidines; Retrospective Studies; Surgical Procedures, Operative; Triazoles; Voriconazole; Young Adult | 2011 |
Antifungal therapy in a murine model of disseminated infection by Cryptococcus gattii.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Male; Mice; Pyrimidines; Triazoles; Voriconazole | 2010 |
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lipopeptides; Micafungin; Mycoses; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2011 |
Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2010 |
Ulcerated plaque under a ruby ring in an immunosuppressed patient.
Topics: Adenine Nucleotides; Aged; Antineoplastic Agents; Arabinonucleosides; Candida; Candidiasis, Cutaneous; Clofarabine; Cytarabine; Dermatologic Agents; Dermatomycoses; Fusarium; Humans; Immunocompromised Host; Itraconazole; Jewelry; Leukemia, Myeloid, Acute; Male; Pyrimidines; Skin Ulcer; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Combined therapy against murine-disseminated infection by Fusarium verticillioides.
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy, Combination; Fusarium; Mice; Mycoses; Pyrimidines; Survival Rate; Triazoles; Voriconazole | 2011 |
In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.
Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Animals; Antifungal Agents; Cryptococcus gattii; Environmental Microbiology; Fluconazole; Flucytosine; Genotype; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2010 |
Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspo
Topics: Anidulafungin; Antifungal Agents; Blood Chemical Analysis; Caspofungin; Chromatography, Liquid; Echinocandins; Humans; Itraconazole; Lipopeptides; Pyrimidines; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2010 |
In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Echinocandins; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cohort Studies; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; France; Fungal Proteins; Hematologic Neoplasms; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Pyrimidines; Triazoles; Tubulin; Voriconazole | 2011 |
Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilution.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Comparison of the broth microdilution methods of the European Committee on Antimicrobial Susceptibility Testing and the Clinical and Laboratory Standards Institute for testing itraconazole, posaconazole, and voriconazole against Aspergillus isolates.
Topics: Antifungal Agents; Aspergillus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of ep
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Drug Combinations; Echinocandins; Enzyme-Linked Immunosorbent Assay; Inhibitory Concentration 50; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Validation of 24-hour posaconazole and voriconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: application of epidemiological cutoff values to results from a global Candida antifungal surveillance program.
Topics: Antifungal Agents; Candida; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2011 |
Aspergillus fumigatus strains with mutations in the cyp51A gene do not always show phenotypic resistance to itraconazole, voriconazole, or posaconazole.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Mutation; Pyrimidines; Triazoles; Voriconazole | 2011 |
Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells.
Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida; Candida albicans; Caspofungin; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Plankton; Pyrimidines; Triazoles; Voriconazole | 2011 |
Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematology; Hospital Costs; Humans; Length of Stay; Lipopeptides; Male; Middle Aged; Models, Economic; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2011 |
Transcriptional profiling of azole-resistant Candida parapsilosis strains.
Topics: Antifungal Agents; Azoles; Candida; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression Profiling; Microbial Sensitivity Tests; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole | 2011 |
A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Child; Child, Preschool; Denmark; Drug Resistance, Fungal; Female; Hospitals; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies; Pyrimidines; Respiratory System; Respiratory Tract Infections; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.
Topics: Animals; Antifungal Agents; Ascomycota; Chromoblastomycosis; Itraconazole; Male; Mice; Mice, Nude; Mitosporic Fungi; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2011 |
Microdilution in vitro antifungal susceptibility of Exophiala dermatitidis, a systemic opportunist.
Topics: Antifungal Agents; Exophiala; Genotype; Humans; Microbial Sensitivity Tests; Phaeohyphomycosis; Pyrimidines; Triazoles; Voriconazole | 2011 |
Peripheral neuropathy in patients on long-term triazole antifungal therapy.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Chronic Disease; Cohort Studies; Female; Humans; Itraconazole; Long-Term Care; Male; Middle Aged; Peripheral Nervous System Diseases; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2011 |
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method.
Topics: Antifungal Agents; Candida; Caspofungin; Culture Media; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Delayed recalcitrant fungal endophthalmitis secondary to Curvularia.
Topics: Abscess; Aged; Amphotericin B; Ascomycota; Cataract Extraction; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Female; Humans; Mycoses; Pyrimidines; Recurrence; Triazoles; Vitrectomy; Vitreous Body; Voriconazole | 2011 |
Selection of resistant fungi in liver transplant recipients during use of newer antifungal agents -- a report of two cases.
Topics: Adult; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fatal Outcome; Female; Fluconazole; Humans; Lipopeptides; Liver Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Trichosporonosis; Voriconazole; Young Adult | 2011 |
Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Brain; Caspofungin; Cerebrum; Echinocandins; Humans; Larynx; Lipopeptides; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Neuroaspergillosis; Paranasal Sinuses; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Sweden; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2012 |
In vitro activities of new triazole antifungal agents, posaconazole and voriconazole, against oral Candida isolates from patients suffering from denture stomatitis.
Topics: Antifungal Agents; Candida; Humans; Microbial Sensitivity Tests; Pyrimidines; Stomatitis, Denture; Triazoles; Voriconazole | 2012 |
Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method.
Topics: Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole | 2011 |
In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
Topics: Animals; Antifungal Agents; Dermatomycoses; Dog Diseases; Dogs; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Miconazole; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: an assessment of currently available triazoles.
Topics: Adolescent; Adult; Antifungal Agents; Coccidioides; Coccidioidomycosis; Cohort Studies; Exostoses; Female; Fluconazole; Fluorides; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Periostitis; Pyrimidines; Triazoles; United States; Voriconazole | 2012 |
In vitro acquisition of secondary azole resistance in Aspergillus fumigatus isolates after prolonged exposure to itraconazole: presence of heteroresistant populations.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Codon; Culture Media; Cytochrome P-450 Enzyme System; DNA Mutational Analysis; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Mycological Typing Techniques; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2012 |
Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.
Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Female; Fungal Proteins; Humans; Itraconazole; Japan; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Mutation; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2012 |
Treatment of refractory coccidioidomycosis with voriconazole or posaconazole.
Topics: Adult; Aged; Antifungal Agents; Coccidioidomycosis; Female; Humans; Male; Middle Aged; Pyrimidines; Retrospective Studies; Salvage Therapy; Southwestern United States; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Medication Adherence; Middle Aged; Mycoses; Myelodysplastic Syndromes; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods.
Topics: Acylation; Aminopyridines; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Fusarium; Glycosylphosphatidylinositols; Humans; Inositol; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2012 |
Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole.
Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Female; Fluconazole; Fungal Proteins; Genotype; Humans; Itraconazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation, Missense; Phenylalanine; Pyrimidines; Sterol 14-Demethylase; Survival Rate; Triazoles; Tyrosine; Voriconazole | 2012 |
New species of Madurella, causative agents of black-grain mycetoma.
Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Fungal Proteins; Humans; Leg; Madurella; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Mycetoma; Phylogeny; Pyrimidines; RNA Polymerase II; Sequence Analysis, DNA; Sudan; Triazoles; Tubulin; Voriconazole | 2012 |
Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species.
Topics: Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Bacterial Typing Techniques; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pseudallescheria; Pyrimidines; Scedosporium; Species Specificity; Triazoles; Voriconazole | 2012 |
Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Longitudinal Studies; Mathematical Computing; Microbial Sensitivity Tests; Models, Statistical; Mutation; Netherlands; Promoter Regions, Genetic; Pyrimidines; Sequence Analysis, DNA; Tandem Repeat Sequences; Triazoles; Voriconazole | 2012 |
Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Asthma; Comorbidity; Drug Utilization; Female; Health Services; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Quality of Life; Radiography, Thoracic; Retrospective Studies; Severity of Illness Index; Socioeconomic Factors; Spirometry; Triazoles; Voriconazole | 2012 |
[Ambulatory therapy of aspergillosis in hematological and oncological patients].
Topics: Ambulatory Care; Antifungal Agents; Caspofungin; Echinocandins; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Neutropenia; Pyrimidines; Salvage Therapy; Triazoles; Voriconazole | 2012 |
High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Drug Resistance, Fungal; France; Humans; In Vitro Techniques; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pyrimidines; Retrospective Studies; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole; Young Adult | 2012 |
Emergence of Aspergillus calidoustus infection in the era of posttransplantation azole prophylaxis.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Female; Humans; Lung Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Retrospective Studies; Risk Factors; Triazoles; Voriconazole | 2012 |
Zygomycosis over-infection during voriconazole therapy for aspergillosis in a heart transplant patient, successfully treated with liposomal amphotericin and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Debridement; Drug Therapy, Combination; Heart Transplantation; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2012 |
Are epidemiologic cut-off values predictors of the in vivo efficacy of azoles in experimental aspergillosis?
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus niger; Disease Models, Animal; Male; Mice; Microbial Sensitivity Tests; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole.
Topics: Adult; Antifungal Agents; Bone Diseases; Female; Fluorides; Hematologic Neoplasms; Humans; Itraconazole; Middle Aged; Muscle, Skeletal; Periostitis; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2012 |
In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disease Models, Animal; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Mice; Mice, Inbred ICR; Mutation, Missense; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Nitriles; Phialophora; Pyridines; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.
Topics: Antifungal Agents; Australia; Cryptococcosis; Cryptococcus gattii; Drug Resistance, Fungal; Europe; Fluconazole; Humans; India; Itraconazole; Microbial Sensitivity Tests; North America; Pyrimidines; South Africa; South America; Triazoles; Voriconazole | 2012 |
The surgical management of rhinocerebral mucormycosis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brain Diseases; Cause of Death; Combined Modality Therapy; Diagnosis, Differential; Fatal Outcome; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Maxillary Sinusitis; Middle Aged; Mucormycosis; Nose Diseases; Paranasal Sinus Diseases; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2013 |
A simple high-performance liquid chromatography method for simultaneous determination of three triazole antifungals in human plasma.
Topics: Antifungal Agents; Calibration; Chromatography, High Pressure Liquid; Humans; Itraconazole; Limit of Detection; Naproxen; Observer Variation; Pyrimidines; Reference Standards; Reproducibility of Results; Triazoles; Voriconazole | 2013 |
Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysis.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Aspergillosis; Drug Evaluation; Female; gamma-Glutamyltransferase; Humans; Liver; Male; Middle Aged; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Major variations in Aspergillus fumigatus arising within aspergillomas in chronic pulmonary aspergillosis.
Topics: Adult; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Female; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Middle Aged; Molecular Typing; Mycological Typing Techniques; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2013 |
In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2013 |
Experimental models of disseminated scedosporiosis with cerebral involvement.
Topics: Animals; Antifungal Agents; Blood-Brain Barrier; Brain; Central Nervous System Fungal Infections; Disease Models, Animal; Dose-Response Relationship, Drug; Immunocompromised Host; Magnetic Resonance Imaging; Male; Pyrimidines; Rats; Rats, Sprague-Dawley; Scedosporium; Survival Analysis; Triazoles; Voriconazole | 2013 |
Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Consolidation Chemotherapy; Economics, Pharmaceutical; Female; Fluconazole; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Genotype; Humans; India; Itraconazole; Microbial Sensitivity Tests; Nitriles; Phenotype; Phylogeny; Polymerase Chain Reaction; Pyridines; Pyrimidines; Sequence Analysis, DNA; Tertiary Care Centers; Triazoles; Voriconazole; Young Adult | 2013 |
In vitro antifungal susceptibility and molecular identity of 99 clinical isolates of the opportunistic fungal genus Curvularia.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Drug Resistance, Multiple, Fungal; Echinocandins; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Pyrimidines; Triazoles; Voriconazole | 2013 |
Antifungal Azoles: Structural Insights into Undesired Tight Binding to Cholesterol-Metabolizing CYP46A1.
Topics: Antifungal Agents; Azoles; Binding Sites; Cholesterol; Cholesterol 24-Hydroxylase; Clotrimazole; Crystallography, X-Ray; Cytochrome P-450 Enzyme System; Humans; Protein Binding; Pyrimidines; Steroid Hydroxylases; Sterol 14-Demethylase; Triazoles; Voriconazole | 2013 |
cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.
Topics: Alleles; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Germany; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Prevalence; Pyrimidines; Triazoles; Voriconazole | 2013 |
In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens.
Topics: Antifungal Agents; Drug Synergism; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Phosphorylcholine; Pyrimidines; Triazoles; Voriconazole | 2013 |
Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.
Topics: Antifungal Agents; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2013 |
In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole.
Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2013 |
Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense.
Topics: Acremonium; Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Echinocandins; Male; Mice; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2013 |
In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2013 |
Invasive Aspergillus niger complex infections in a Belgian tertiary care hospital.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus niger; Belgium; Female; Humans; Incidence; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Mycological Typing Techniques; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole | 2014 |
Scedosporium prolificans fungaemia in a patient with acute lymphoblastic leukaemia.
Topics: Allografts; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Drug Substitution; Fatal Outcome; Female; Fluconazole; Fungemia; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Scedosporium; Triazoles; Voriconazole; Young Adult | 2013 |
A reference laboratory experience of clinically achievable voriconazole, posaconazole, and itraconazole concentrations within the bloodstream and cerebral spinal fluid.
Topics: Antifungal Agents; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2014 |
Azole-based chemoprophylaxis of invasive fungal infections in paediatric patients with acute leukaemia: an internal audit.
Topics: Adolescent; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Cohort Studies; Female; Humans; Infant; Leukemia; Male; Mycoses; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2014 |
In vitro evaluation of antifungal drug combinations against Sarocladium (Acremonium) kiliense, an opportunistic emergent fungus resistant to antifungal therapies.
Topics: Acremonium; Amphotericin B; Anidulafungin; Antifungal Agents; Drug Combinations; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2014 |
Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Remission Induction; Retrospective Studies; Secondary Prevention; Tertiary Care Centers; Triazoles; Voriconazole | 2014 |
Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Echinocandins; Fungemia; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole | 2014 |
Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole.
Topics: Antifungal Agents; Candida; Fluconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2014 |
Effectiveness of primary anti-Aspergillus prophylaxis during remission induction chemotherapy of acute myeloid leukemia.
Topics: Aged; Antifungal Agents; Aspergillus; Echinocandins; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Retrospective Studies; Risk Factors; Triazoles; Voriconazole | 2014 |
Does fungicide application in vineyards induce resistance to medical azoles in Aspergillus species?
Topics: Adaptation, Physiological; Agriculture; Antifungal Agents; Aspergillus; Azoles; Environmental Monitoring; Fungicides, Industrial; Humans; Itraconazole; Microbial Sensitivity Tests; Portugal; Pyrimidines; Triazoles; Voriconazole; Wine | 2014 |
Alopecia and nail changes associated with voriconazole therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Antifungal Agents; Cross-Sectional Studies; Disease Outbreaks; Female; Humans; Male; Methylprednisolone; Michigan; Middle Aged; Mycoses; Nails; Prevalence; Triazoles; Voriconazole | 2014 |
Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Aged; Algorithms; Antifungal Agents; Azoles; Drug Dosage Calculations; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Retrospective Studies; Sirolimus; Tacrolimus; Triazoles; Voriconazole; Young Adult | 2015 |
Posaconazole responsive cerebral aspergillosis in an immunocompetent adult.
Topics: Aged; Antifungal Agents; Aspergillosis; Brain; Encephalitis; Humans; Magnetic Resonance Imaging; Male; Suction; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Experimental treatment of Curvularia infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Disease Models, Animal; Immunocompromised Host; Male; Mice; Mycoses; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(®) registry.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Canada; Female; Fusariosis; Fusarium; Humans; Male; Middle Aged; Prospective Studies; Registries; Survival Analysis; Treatment Outcome; Triazoles; United States; Voriconazole; Young Adult | 2014 |
Cysticidal activity of antifungals against different genotypes of Acanthamoeba.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Amebiasis; Antifungal Agents; Cysts; Humans; Parasitic Sensitivity Tests; Triazoles; Voriconazole | 2014 |
Experimental therapy with azoles against Candida guilliermondii.
Topics: Antifungal Agents; Azoles; Candida; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2014 |
Cryptic and rare Aspergillus species in Brazil: prevalence in clinical samples and in vitro susceptibility to triazoles.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Brazil; Calmodulin; Cluster Analysis; DNA, Fungal; DNA, Ribosomal Spacer; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Prevalence; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole | 2014 |
Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole.
Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Molecular Sequence Data; Mutation, Missense; Sequence Analysis, DNA; Triazoles; Voriconazole | 2014 |
Last generation triazoles for imported eumycetoma in eleven consecutive adults.
Topics: Adolescent; Adult; Antifungal Agents; beta-Glucans; Child; Exophiala; Fluorodeoxyglucose F18; Fusarium; Humans; Madurella; Magnetic Resonance Imaging; Male; Mycetoma; Positron-Emission Tomography; Proteoglycans; Retrospective Studies; Skin; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2014 |
Keratitis caused by Absidia corymbifera in an immunocompetent male with no corneal injuries.
Topics: Absidia; Administration, Ophthalmic; Adrenal Cortex Hormones; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Combined Modality Therapy; Corneal Transplantation; Corneal Ulcer; Drug Therapy, Combination; Humans; Immunocompetence; Male; Middle Aged; Mucormycosis; Ophthalmic Solutions; Staining and Labeling; Triazoles; Voriconazole | 2015 |
Efficacy of oleylphosphocholine (OlPC) in vitro and in a mouse model of invasive aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Azoles; Disease Models, Animal; Mice; Microbial Sensitivity Tests; Phosphorylcholine; Pyrimidines; Triazoles; Voriconazole | 2015 |
Successful long-term management of invasive cerebral fungal infection following liver transplantation.
Topics: Antifungal Agents; Aspergillus; Aspergillus flavus; Brain Diseases; Central Nervous System Fungal Infections; Drug Therapy, Combination; Humans; Liver Transplantation; Male; Middle Aged; Neuroaspergillosis; Radiography; Scedosporium; Triazoles; Voriconazole | 2015 |
In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Azoles; Candida; China; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Mutation; Rhodotorula; Sequence Analysis, DNA; Triazoles; Trichosporon; Voriconazole | 2015 |
Use of posaconazole delayed-release tablets for treatment of invasive aspergillosis.
Topics: Aged; Antifungal Agents; Brain; Brain Abscess; Delayed-Action Preparations; Humans; Male; Neuroaspergillosis; Tablets; Treatment Outcome; Triazoles; Voriconazole | 2015 |
In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Epidermophyton; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Nitriles; Pyridines; Terbinafine; Tinea; Triazoles; Trichophyton; Voriconazole | 2015 |
Posaconazole liquid suspension in solid organ transplant recipients previously treated with voriconazole.
Topics: Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Mucormycosis; Mycoses; Transplant Recipients; Transplants; Triazoles; Voriconazole | 2015 |
Multi-triazole-resistant Aspergillus fumigatus infections in Australia.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Australia; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Retrospective Studies; Triazoles; Voriconazole | 2015 |
Breakthrough invasive fungal infection under the use of posaconazole and voriconazole.
Topics: Antifungal Agents; Colletotrichum; Drug Resistance, Multiple, Fungal; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Opportunistic Infections; Triazoles; Voriconazole | 2016 |
Genetic Analysis Using an Isogenic Mating Pair of Aspergillus fumigatus Identifies Azole Resistance Genes and Lack of MAT Locus's Role in Virulence.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Crosses, Genetic; Drug Resistance, Multiple, Fungal; Fungal Proteins; Genes, Mating Type, Fungal; Genetic Loci; Hydroxymethylglutaryl CoA Reductases; Itraconazole; Larva; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mixed Function Oxygenases; Moths; Mutation; Sterol 14-Demethylase; Survival Analysis; Triazoles; Virulence; Voriconazole | 2015 |
First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA Mutational Analysis; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Promoter Regions, Genetic; Triazoles; Turkey; Voriconazole; Young Adult | 2015 |
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole | 2015 |
In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates.
Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Genotype; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
In vivo efficacy of voriconazole and posaconazole therapy in a novel invertebrate model of Aspergillus fumigatus infection.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Larva; Lepidoptera; Microbial Sensitivity Tests; Survival Analysis; Triazoles; Voriconazole | 2015 |
In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
Contribution of a Simple Bioassay in Effective Therapeutic Drug Monitoring of Posaconazole and Voriconazole.
Topics: Antifungal Agents; Biological Assay; Blood Proteins; Calibration; Drug Monitoring; Humans; Protein Binding; Triazoles; Voriconazole | 2015 |
Azole resistance in canine and feline isolates of Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cat Diseases; Cats; Cytochrome P-450 Enzyme System; Dog Diseases; Dogs; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole | 2015 |
Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae.
Topics: Agar; Animals; Antifungal Agents; Culture Media; Disease Models, Animal; Drosophila melanogaster; Female; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Rhizopus; Survival Analysis; Triazoles; Virulence; Voriconazole | 2015 |
Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B against Molecularly Identified Mucorales Species.
Topics: Amphotericin B; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Nitriles; Pyridines; Species Specificity; Triazoles; Voriconazole | 2015 |
Voriconazole and posaconazole therapy for experimental Candida lusitaniae infection.
Topics: Animals; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Kidney; Male; Mice; Proteoglycans; Treatment Outcome; Triazoles; Voriconazole | 2016 |
Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Topics: Alleles; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Candida glabrata; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Humans; Itraconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Nitriles; Protein Isoforms; Pyridines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Triazoles; Voriconazole | 2016 |
Aspergillus Mediastinitis after Orthotopic Heart Transplantation: A Case Report.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Combined Modality Therapy; Debridement; Drainage; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Transplantation; Humans; Mediastinitis; Middle Aged; Reoperation; Surgical Flaps; Surgical Wound Infection; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2015 |
Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Humans; Iran; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Mycological Typing Techniques; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Retrospective Studies; Sequence Analysis, DNA; Triazoles; Voriconazole | 2016 |
In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.
Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Azoles; Coordination Complexes; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Peptides, Cyclic; Triazoles; Voriconazole | 2016 |
Azole Resistance in Aspergillus fumigatus Clinical Isolates from an Italian Culture Collection.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bacterial Typing Techniques; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Epidemiological Monitoring; Fungal Proteins; Gene Expression; Genotype; Humans; Italy; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Mutation; Promoter Regions, Genetic; Triazoles; Voriconazole | 2016 |
Molecular Characterization of a Voriconazole-Resistant, Posaconazole-Susceptible Aspergillus fumigatus Isolate in a Lung Transplant Recipient in the United States.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Cytomegalovirus Infections; Drug Resistance, Fungal; Fungal Proteins; Humans; Lung Transplantation; Male; Microbial Sensitivity Tests; Transplant Recipients; Triazoles; United States; Voriconazole | 2016 |
A combination approach to treating fungal infections.
Topics: Antifungal Agents; Candida albicans; Cell Line, Tumor; Cell Survival; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Epithelial Cells; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Species Specificity; Tobramycin; Triazoles; Voriconazole | 2015 |
Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Eye; Eye Infections, Fungal; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
Quantification of the Triazole Antifungal Compounds Voriconazole and Posaconazole in Human Serum or Plasma Using Liquid Chromatography Electrospray Tandem Mass Spectrometry (HPLC-ESI-MS/MS).
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2016 |
Virulence and Resistance to Antifungal Therapies of Scopulariopsis Species.
Topics: Amphotericin B; Animals; Antifungal Agents; Cyclophosphamide; Disease Models, Animal; Drug Resistance, Fungal; Humans; Immunocompromised Host; Male; Mice; Mycoses; Neutropenia; Scopulariopsis; Species Specificity; Survival Analysis; Triazoles; Virulence; Voriconazole | 2016 |
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Epidemiologic Methods; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
In vitro activities of five antifungal agents against 199 clinical and environmental isolates of Aspergillus flavus, an opportunistic fungal pathogen.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Environmental Microbiology; Humans; Iran; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Opportunistic Infections; Triazoles; Voriconazole | 2016 |
In Vitro Interactions between Target of Rapamycin Kinase Inhibitor and Antifungal Agents against Aspergillus Species.
Topics: Amphotericin B; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Benzoxazoles; Caspofungin; Drug Combinations; Drug Synergism; Echinocandins; Fungal Proteins; Gene Expression; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; TOR Serine-Threonine Kinases; Triazoles; Voriconazole | 2016 |
[NEW ANTIFUNGAL DRUGS FOR PREVENTION AND TREATMENT OF VISCERAL MYCOSES].
Topics: Antifungal Agents; Caspofungin; Drug Therapy; Echinocandins; Humans; Lipopeptides; Micafungin; Mycoses; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole | 2015 |
Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.
Topics: Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Echinocandins; Fluconazole; HEK293 Cells; Humans; Itraconazole; Lipopeptides; Micafungin; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Triazoles; Voriconazole | 2016 |
Drug-Drug Interaction Associated with Mold-Active Triazoles among Hospitalized Patients.
Topics: Antifungal Agents; Drug Interactions; Hospitalization; Humans; Itraconazole; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
Posaconazole Substitution for Voriconazole-Associated Phototoxic Effects.
Topics: Aged; Antifungal Agents; Chronic Disease; Dermatitis, Phototoxic; Exophiala; Female; Follow-Up Studies; Humans; Meningitis, Fungal; Phaeohyphomycosis; Retreatment; Risk Assessment; Treatment Outcome; Triazoles; Voriconazole | 2016 |
Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India.
Topics: Amphotericin B; Antifungal Agents; Female; Fluconazole; Genotype; Humans; India; Itraconazole; Male; Microbial Sensitivity Tests; Mycological Typing Techniques; Phenotype; Sequence Analysis, DNA; Triazoles; Trichosporon; Trichosporonosis; Voriconazole | 2016 |
Fungal infection of cystic fibrosis patients - single center experience.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Candida albicans; Candida tropicalis; Cystic Fibrosis; Drug Resistance, Multiple, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Scedosporium; Triazoles; Voriconazole; Yeasts | 2016 |
Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Species Specificity; Triazoles; Voriconazole | 2016 |
Identification of Ebsulfur Analogues with Broad-Spectrum Antifungal Activity.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Candida; Fluconazole; HEK293 Cells; Hemolysis; Heterocyclic Compounds, 2-Ring; Humans; Itraconazole; Mice; Microbial Sensitivity Tests; Reactive Oxygen Species; Structure-Activity Relationship; Thiazoles; Triazoles; Voriconazole | 2016 |
Recurrent trichosporonosis with central nervous system involvement in an allogeneic hematopoietic stem cell transplant recipient.
Topics: Anemia, Aplastic; Antibiotic Prophylaxis; Antifungal Agents; Caspofungin; Central Nervous System; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydrocephalus; Immunocompromised Host; Immunosuppression Therapy; Laminectomy; Lipopeptides; Magnetic Resonance Imaging; Opportunistic Infections; Recurrence; Transplantation, Autologous; Treatment Outcome; Triazoles; Trichosporon; Trichosporonosis; Ventriculoperitoneal Shunt; Voriconazole | 2016 |
Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant.
Topics: Adult; Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Itraconazole; Spain; Triazoles; Voriconazole | 2017 |
Aspergillus fumigatus carrying TR34/L98H resistance allele causing complicated suppurative otitis media in Tanzania: Call for improved diagnosis of fungi in sub-Saharan Africa.
Topics: Adolescent; Adult; Alleles; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Female; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Otitis Media, Suppurative; Tanzania; Triazoles; Voriconazole; Young Adult | 2016 |
Antimold Prophylaxis May Reduce the Risk of Invasive Fusariosis in Hematologic Patients with Superficial Skin Lesions with Positive Culture for Fusarium.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antifungal Agents; Female; Fusariosis; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Intertrigo; Leukemia; Male; Middle Aged; Onychomycosis; Prospective Studies; Skin; Triazoles; Voriconazole; Young Adult | 2016 |
Genotyping of Aspergillus fumigatus Reveals Compartmentalization of Genotypes in Disseminated Disease after Invasive Pulmonary Aspergillosis.
Topics: Adrenal Cortex Hormones; Adult; Antifungal Agents; Aspergillus fumigatus; Female; Genotype; Graft vs Host Disease; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Male; Microbial Sensitivity Tests; Microsatellite Repeats; Molecular Typing; Mycological Typing Techniques; Triazoles; Voriconazole | 2017 |
Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species.
Topics: Amphotericin B; Antifungal Agents; Fungal Proteins; Fusarium; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2017 |
A rapid UPLC-MS/MS assay for the simultaneous measurement of fluconazole, voriconazole, posaconazole, itraconazole, and hydroxyitraconazole concentrations in serum.
Topics: Antifungal Agents; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Fluconazole; Humans; Itraconazole; Limit of Detection; Reproducibility of Results; Tandem Mass Spectrometry; Time Factors; Triazoles; Voriconazole | 2017 |
Tintelnotia, a new genus in Phaeosphaeriaceae harbouring agents of cornea and nail infections in humans.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Cornea; Echinocandins; Eye Infections, Fungal; Female; Humans; Itraconazole; Keratitis; Lipopeptides; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Phylogeny; Terbinafine; Triazoles; Voriconazole | 2017 |
Synergistic Effects of Tetrandrine with Posaconazole Against Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzylisoquinolines; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Female; Humans; Itraconazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2017 |
Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients.
Topics: Antifungal Agents; Biomarkers; Cytochrome P-450 CYP3A; Drug Interactions; Female; Follow-Up Studies; Genotype; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Male; Middle Aged; Organ Transplantation; Polymorphism, Single Nucleotide; Postoperative Complications; Prognosis; Retrospective Studies; Risk Factors; Tacrolimus; Triazoles; Voriconazole | 2017 |
Prophylaxis with Isavuconazole or Posaconazole Protects Immunosuppressed Mice from Pulmonary Mucormycosis.
Topics: Animals; Antibiotic Prophylaxis; Antifungal Agents; Disease Models, Animal; Immunosuppression Therapy; Lung Diseases, Fungal; Mice; Mucormycosis; Nitriles; Pyridines; Rhizopus; Triazoles; Voriconazole | 2017 |
Comparing Azole Plasma Trough Levels in Lung Transplant Recipients: Percentage of Therapeutic Levels and Intrapatient Variability.
Topics: Antifungal Agents; Azoles; Drug Monitoring; Female; Humans; Itraconazole; Lung Transplantation; Male; Middle Aged; Plasma; Retrospective Studies; Tablets; Transplant Recipients; Triazoles; Voriconazole | 2017 |
Cutaneous phaeohyphomycosis in a hematopoietic stem cell transplant patient caused by Alternaria rosae: First case report.
Topics: Acute Kidney Injury; Acyclovir; Aged; Alternaria; Alternariosis; Antibiotic Prophylaxis; Antifungal Agents; Drug Therapy, Combination; Fatal Outcome; Graft vs Host Disease; Hand; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Levofloxacin; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Paranasal Sinuses; Phaeohyphomycosis; Pneumonia; Prednisone; Primary Myelofibrosis; Respiratory Insufficiency; Spores, Fungal; Transplantation, Homologous; Triazoles; Voriconazole | 2017 |
Triazole Resistance in
Topics: Antifungal Agents; Aspergillus fumigatus; China; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Promoter Regions, Genetic; Tandem Repeat Sequences; Triazoles; Voriconazole | 2017 |
Topics: Aged; Antifungal Agents; Aspergillosis; Brain; Female; Humans; Immunocompromised Host; Lung Diseases, Fungal; Triazoles; Voriconazole | 2017 |
Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans.
Topics: Antifungal Agents; Ascomycota; Caspofungin; Dihydroorotate Dehydrogenase; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Oxidoreductases Acting on CH-CH Group Donors; Scedosporium; Triazoles; Voriconazole | 2017 |
Changing epidemiology of candidaemia in Australia.
Topics: Anidulafungin; Antifungal Agents; Australia; Azoles; Candida; Candida glabrata; Candida tropicalis; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Incidence; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole | 2017 |
Clinical effectiveness of early posaconazole suspension pre-emptive therapy in lung transplant recipients: The Alfred's experience.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cohort Studies; Drug Monitoring; Female; Humans; Lung Transplantation; Male; Middle Aged; Retrospective Studies; Suspensions; Transplant Recipients; Treatment Outcome; Triazoles; Voriconazole | 2017 |
Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Cohort Studies; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Ergosterol; Female; Fungal Proteins; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Microbial Sensitivity Tests; Polymorphism, Genetic; Prospective Studies; Tertiary Healthcare; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2017 |
Susceptibility Testing of Common and Uncommon Aspergillus Species against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Sterol 14-Demethylase; Triazoles; Voriconazole | 2017 |
A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidemia; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Incidence; Infant; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Peru; Prospective Studies; Triazoles; Voriconazole; Young Adult | 2017 |
Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemoprevention; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Hospitals, University; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Survival Analysis; Texas; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2017 |
Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Analysis of Fluconazole, Isavuconazole, Itraconazole, Hydroxy-Itraconazole, Posaconazole, and Voriconazole in Human Plasma and Serum.
Topics: Acetonitriles; Adult; Antifungal Agents; Calibration; Chromatography, Liquid; Drug Monitoring; Female; Fluconazole; Humans; Indicators and Reagents; Isotope Labeling; Itraconazole; Nitriles; Plasma; Pyridines; Reproducibility of Results; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2017 |
Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a
Topics: Aged; Alleles; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Azoles; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Lipopeptides; Male; Microbial Sensitivity Tests; Mutation; Treatment Outcome; Triazoles; Voriconazole | 2017 |
Effects of Photodynamic Therapy on the Growth and Antifungal Susceptibility of Scedosporium and Lomentospora spp.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Humans; Immunocompromised Host; Itraconazole; Methylene Blue; Microbial Sensitivity Tests; Photochemotherapy; Photosensitizing Agents; Scedosporium; Triazoles; Voriconazole | 2017 |
Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study.
Topics: Administration, Intravenous; Administration, Oral; Adult; Antifungal Agents; Colorado; Drug Compounding; Drug Monitoring; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2017 |
Synergistic Effects of Tacrolimus and Azoles against Exophiala dermatitidis.
Topics: Antifungal Agents; Biofilms; Calcineurin Inhibitors; Candida parapsilosis; Drug Synergism; Exophiala; Humans; Itraconazole; Microbial Sensitivity Tests; Phaeohyphomycosis; Tacrolimus; Triazoles; Voriconazole | 2017 |
Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavus.
Topics: Acetamides; Animals; Antifungal Agents; Aspergillus flavus; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Invasive Pulmonary Aspergillosis; Mice; Piperazines; Pyrimidines; Pyrroles; Triazoles; Voriconazole | 2018 |
Diversity of clinical isolates of Aspergillus terreus in antifungal susceptibilities, genotypes and virulence in Galleria mellonella model: Comparison between respiratory and ear isolates.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Ear; Genotype; Hospitals, University; Humans; Itraconazole; Lepidoptera; Microsatellite Repeats; Respiratory System; Triazoles; Voriconazole | 2017 |
Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole | 2018 |
Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study.
Topics: Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillus; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Male; Neutropenia; Nitriles; Pyridines; Transaminases; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2018 |
Persistent CNS toxicity in a patient receiving posaconazole tablets after discontinuation of voriconazole due to supratherapeutic serum levels.
Topics: Antifungal Agents; Brain Diseases; Humans; Male; Middle Aged; Serum; Tablets; Triazoles; Voriconazole | 2018 |
Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran: comparison of colonizing and infecting isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cross-Sectional Studies; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Hospitals, University; Humans; Immunocompromised Host; Iran; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2017 |
The challenges of treating aspergillus abdominal aneurysm after hematopoietic cell transplant: Rapid voriconazole metabolizer.
Topics: Aneurysm, Infected; Antifungal Agents; Aspergillosis; Cytochrome P-450 CYP2C19; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Triazoles; Voriconazole | 2019 |
Candida infanticola and Candida spencermartinsiae yeasts: Possible emerging species in cancer patients.
Topics: Adolescent; Antifungal Agents; Candida; Candidiasis; Caspofungin; Child, Preschool; Echinocandins; Fluconazole; Humans; Kluyveromyces; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Nitriles; Opportunistic Infections; Pichia; Pyridines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole | 2018 |
Comparative evaluation of different gradient diffusion tests for detection of azole resistance in Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Reproducibility of Results; Triazoles; Voriconazole | 2018 |
Topics: Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Endophthalmitis; Eye; Female; Fusarium; Humans; Hyphae; Immunocompromised Host; Leukemia, Myeloid, Acute; Treatment Outcome; Triazoles; Vitrectomy; Voriconazole | 2018 |
Posaconazole-Induced Pseudohyperaldosteronism.
Topics: Aged; Antifungal Agents; Heart Failure; Histoplasmosis; Humans; Hydroxysteroid Dehydrogenases; Hyperaldosteronism; Hypertension; Hypokalemia; Mineralocorticoid Excess Syndrome, Apparent; Triazoles; Voriconazole | 2018 |
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Bronchoalveolar Lavage; Disease Management; Early Diagnosis; Flucytosine; Galactose; Humans; Immunocompromised Host; Immunologic Tests; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Mannans; Microbial Sensitivity Tests; Myelodysplastic Syndromes; Nitriles; Pyridines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2018 |
Anti-candidal activity of selected analgesic drugs used alone and in combination with fluconazole, itraconazole, voriconazole, posaconazole and isavuconazole.
Topics: Acetaminophen; Analgesics; Antifungal Agents; Aspirin; Candida; Candida albicans; Candida glabrata; Candidiasis; Dipyrone; Drug Resistance, Fungal; Fluconazole; Humans; Ibuprofen; Itraconazole; Meloxicam; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole | 2018 |
Posaconazole vs. voriconazole in the prevention of invasive fungal diseases in patients with haematological malignancies: A retrospective study.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; China; Cost-Benefit Analysis; Female; Fluconazole; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Itraconazole; Male; Middle Aged; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2018 |
Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical Trials.
Topics: Antifungal Agents; Clinical Trials as Topic; Humans; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole | 2018 |
Simultaneous quantification of systemic azoles and their major metabolites in human serum by HPLC/PDA: role of azole metabolic rate.
Topics: Antifungal Agents; Azoles; Chromatography, High Pressure Liquid; Humans; Itraconazole; Serum; Triazoles; Voriconazole | 2018 |
Disseminated Exophiala dermatitidis causing septic arthritis and osteomyelitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Arthritis, Infectious; Exophiala; Female; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Osteomyelitis; Phaeohyphomycosis; Triazoles; Voriconazole | 2018 |
A vexing case of bone pain in a renal transplant recipient: Voriconazole-induced periostitis.
Topics: Antifungal Agents; Drug Substitution; Graft Rejection; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Kidney Transplantation; Male; Middle Aged; Periostitis; Transplant Recipients; Triazoles; Voriconazole | 2018 |
Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species.
Topics: Antifungal Agents; Aspergillus; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2018 |
Quantification of Serum Voriconazole, Isavuconazole, and Posaconazole by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS).
Topics: Antifungal Agents; Chromatography, Liquid; Humans; Nitriles; Pyridines; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2018 |
Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Candida glabrata; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Humans; Itraconazole; Lanosterol; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Sterol 14-Demethylase; Triazoles; Voriconazole | 2018 |
Treatment of Suspected Invasive Fungal Infection in War Wounds.
Topics: Administration, Topical; Afghan Campaign 2001-; Amphotericin B; Antifungal Agents; beta-Cyclodextrins; Debridement; Excipients; Humans; Mycoses; Recurrence; Risk Factors; Tobramycin; Treatment Outcome; Triazoles; Vancomycin; Voriconazole; Wounds and Injuries | 2018 |
Diagnosis and Treatment of Invasive Aspergillus fumigatus Wound Infection Following Subtotal Colectomy for Perforated Toxic Megacolon in an Immunosuppressed Patient.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colectomy; Debridement; Female; Humans; Immunocompromised Host; Megacolon, Toxic; Postoperative Complications; Surgical Wound Infection; Treatment Outcome; Triazoles; Voriconazole | 2018 |
Posaconazole versus voriconazole as antifungal prophylaxis during induction therapy for acute myelogenous leukemia or myelodysplastic syndrome.
Topics: Adult; Aged; Antifungal Agents; Female; Humans; Induction Chemotherapy; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Triazoles; Voriconazole | 2019 |
Impact of Antifungal Compounds on Viability and Anti-
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Cell Survival; Deoxycholic Acid; Doxorubicin; Drug Combinations; Fluconazole; Humans; Killer Cells, Natural; Microbial Sensitivity Tests; Polyethylene Glycols; Triazoles; Voriconazole | 2019 |
Yeast-like filamentous fungi: Molecular identification and in vitro susceptibility study.
Topics: Antifungal Agents; DNA, Fungal; Fluconazole; Fungi; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Triazoles; Voriconazole | 2019 |
The Evolution of Azole Resistance in
Topics: Amino Acid Sequence; Antifungal Agents; Azoles; Candida albicans; Fluconazole; Fungal Proteins; Itraconazole; Mutation; Protein Binding; Sterol 14-Demethylase; Triazoles; Voriconazole | 2019 |
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult | 2019 |
First fungemia case due to environmental yeast Wickerhamomyces myanmarensis: detection by multiplex qPCR and antifungal susceptibility.
Topics: Antifungal Agents; Child; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Male; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; Saccharomycetales; Triazoles; Voriconazole | 2019 |
Why do lung transplant patients discontinue triazole prophylaxis?
Topics: Adult; Aged; Antifungal Agents; Drug Interactions; Female; Humans; Invasive Fungal Infections; Itraconazole; Lung Transplantation; Male; Medication Adherence; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Voriconazole | 2019 |
Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical center.
Topics: Academic Medical Centers; Adult; Aged; Antifungal Agents; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2019 |
Antifungal Drugs Influence Neutrophil Effector Functions.
Topics: Amphotericin B; Antifungal Agents; Interleukin-8; Neutrophils; Nitriles; Phagocytosis; Pyridines; Triazoles; Voriconazole | 2019 |
Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection.
Topics: Administration, Topical; Antifungal Agents; Aspergillus fumigatus; Benzamides; Cell Line; Drug Synergism; Humans; Pulmonary Alveoli; Pulmonary Aspergillosis; Triazoles; Voriconazole | 2019 |
Impact of Triazole Therapeutic Drug Monitoring Availability and Timing.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Monitoring; Female; Humans; Invasive Fungal Infections; Itraconazole; Male; Middle Aged; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2019 |
Aerosolization of Second-generation Triazoles: In Vitro Evaluation and Application in Therapy of Invasive Airway Aspergillosis.
Topics: Administration, Inhalation; Adult; Aerosols; Antifungal Agents; Aspergillosis; Bronchoscopy; Feasibility Studies; Female; Humans; Invasive Fungal Infections; Lung Transplantation; Respiratory Tract Infections; Triazoles; Voriconazole | 2019 |
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Triazoles; Voriconazole | 2019 |
Use of triazoles for the treatment of invasive aspergillosis: A three-year cohort analysis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Cohort Studies; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole | 2020 |
Simultaneous quantitation of five triazole anti-fungal agents by paper spray-mass spectrometry.
Topics: Antifungal Agents; Dried Blood Spot Testing; Drug Monitoring; Fluconazole; Humans; Isotope Labeling; Laboratories; Limit of Detection; Paper; Reference Standards; Reproducibility of Results; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2020 |
[Cryptic Aspergillus species - a case report of chronic cavitary pulmonary Aspergillus lentulus infection in a heart transplant recipient].
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Heart Transplantation; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Transplant Recipients; Triazoles; Voriconazole | 2019 |
Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection.
Topics: Adolescent; Adult; Allografts; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2018 |
Synergistic effects of vorinostat (SAHA) and azoles against Aspergillus species and their biofilms.
Topics: Aspergillus; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; Azoles; Biofilms; Drug Synergism; Gene Expression Regulation; HSP90 Heat-Shock Proteins; Itraconazole; Microbial Sensitivity Tests; Plankton; Triazoles; Voriconazole; Vorinostat | 2020 |
Novel Application of Pentabromobenzyl Column for Simultaneous Determination of Eight Antifungal Drugs Using High-performance Liquid Chromatography.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Clotrimazole; Humans; Hydrocarbons, Brominated; Imidazoles; Ketoconazole; Liquid-Liquid Extraction; Molecular Structure; Thiophenes; Triazoles; Voriconazole | 2020 |
In vitro activity of isavuconazole versus opportunistic filamentous fungal pathogens from the SENTRY Antifungal Surveillance Program, 2017-2018.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Nitriles; Public Health Surveillance; Pyridines; Triazoles; Voriconazole | 2020 |
Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
Topics: Aged; Antifungal Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Incidence; Itraconazole; Lung Transplantation; Male; Middle Aged; Pulmonary Aspergillosis; Skin Neoplasms; Triazoles; United States; Voriconazole | 2020 |
Successful challenge of voriconazole in a patient with posaconazole-associated minor drug eruption: A case report.
Topics: Adult; Antifungal Agents; Diagnosis, Differential; Drug Eruptions; Female; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Triazoles; Voriconazole | 2020 |
Antifungal susceptibility profile and molecular identification of Cyp51C mutations in clinical and environmental isolates of Aspergillus flavus from Argentina.
Topics: Amphotericin B; Antifungal Agents; Argentina; Aspergillosis; Aspergillus flavus; Cytochrome P450 Family 51; Drug Resistance, Fungal; Environmental Microbiology; Environmental Monitoring; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole | 2021 |
Dementia-Like Symptoms Associated With Posaconazole.
Topics: Antifungal Agents; Dementia; Humans; Triazoles; Voriconazole | 2022 |
Differential Impacts of Azole Antifungal Drugs on the Pharmacokinetic Profiles of Dasatinib in Rats by LC-MS-MS.
Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dasatinib; Drug Interactions; Drug Monitoring; Humans; Itraconazole; Ketoconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Models, Animal; Protein Kinase Inhibitors; Rats; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2020 |
Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Caspofungin; DNA, Fungal; DNA, Ribosomal Spacer; Fluconazole; Humans; Imidazoles; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Rhodotorula; Species Specificity; Triazoles; Voriconazole | 2020 |
Identification and in vitro antifungal susceptibility of causative agents of onychomycosis due to Aspergillus species in Mashhad, Iran.
Topics: Antifungal Agents; Aspergillus; Calmodulin; Fungal Proteins; Humans; Iran; Microbial Sensitivity Tests; Nitriles; Onychomycosis; Pyridines; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Tubulin; Voriconazole | 2021 |
Clinical utility of antifungal susceptibility testing in patients with fungal rhinosinusitis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Mycoses; Sinusitis; Triazoles; Voriconazole | 2021 |
Comparison of Disc Diffusion, Etest, and a Modified CLSI Broth Microdilution Method for
Topics: Antifungal Agents; Disk Diffusion Antimicrobial Tests; Itraconazole; Madurella; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2021 |
In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years.
Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Europe; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; North America; Opportunistic Infections; Triazoles; Voriconazole | 2021 |
Azole resistance in Aspergillus fumigatus isolates from respiratory specimens in Lyon University Hospitals, France: prevalence and mechanisms involved.
Topics: Antifungal Agents; Aspergillus fumigatus; Cross-Sectional Studies; Cytochrome P-450 Enzyme System; France; Fungal Proteins; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Nitriles; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Pyridines; Respiratory Tract Infections; Retrospective Studies; Triazoles; Tubulin; Voriconazole | 2021 |
Evaluation of Voriconazole and Posaconazole Dosing in Patients With Thermal Burn Injuries.
Topics: Adult; Antifungal Agents; Azoles; Burns; Humans; Retrospective Studies; Triazoles; Voriconazole | 2022 |
Topics: Antifungal Agents; Aspergillus; Azoles; Candida; Candida albicans; Drug Resistance, Fungal; Exophiala; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Morpholines; Sirolimus; TOR Serine-Threonine Kinases; Triazoles; Voriconazole | 2022 |
Papilledema and idiopathic intracranial hypertension due to the possible potentiation of ATRA by posaconazole in a case of acute promyelocytic leukemia.
Topics: Adult; Fluconazole; Humans; Leukemia, Promyelocytic, Acute; Male; Papilledema; Pseudotumor Cerebri; Tretinoin; Triazoles; Voriconazole; Young Adult | 2022 |
Antifungal prophylactic effectiveness and intrapulmonary concentrations of voriconazole versus posaconazole in lung transplant recipients.
Topics: Animals; Antifungal Agents; Humans; Invasive Fungal Infections; Lung; Retrospective Studies; Transplant Recipients; Triazoles; Voriconazole | 2022 |
Incidence of breakthrough fungal infections on isavuconazole prophylaxis compared to posaconazole and voriconazole.
Topics: Antifungal Agents; Female; Humans; Incidence; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Mycoses; Prospective Studies; Retrospective Studies; Voriconazole | 2023 |
Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Program (2018-2021) and application of single-site epidemiological c
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Azoles; Caspofungin; Drug Resistance, Fungal; Fungi; Itraconazole; Microbial Sensitivity Tests; Voriconazole | 2023 |
Comparative study of posaconazole and voriconazole for primary antifungal prophylaxis in patients with pediatric acute leukemia.
Topics: Antifungal Agents; Child; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Retrospective Studies; Triazoles; Voriconazole | 2023 |
Triazole Antifungal Quantification for Therapeutic Drug Monitoring in Serum by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS): Posaconazole, Voriconazole, Itraconazole, and Hydroxyitraconazole.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Chromatography, Liquid; Drug Monitoring; Itraconazole; Methanol; Reproducibility of Results; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2024 |